Recoverable chiral auxiliary for the stereo-controlled preparation of phoshorothioate oligonucleotides and design of proline derivatives for aldol reactions by LIU HAI
  
RECOVERABLE CHIRAL AUXILIARY FOR THE       
STEREO-CONTROLLED PREPARATION OF  
PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND    

































 RECOVERABLE CHIRAL AUXILIARY FOR THE 
STEREO-CONTROLLED PREPARATION OF PS-OLIGOS 
AND DESIGN OF PROLINE DERIVATIVES  





SUBMIT TO THE 
 
NATIONAL UNIVERSITY OF 
 
SINGAPORE FOR THE DEGREE OF 
 












DEPARTMENT OF CHEMISTRY 











     
 
First of all, I would like to thank my supervisor, Dr Lu Yixin for his invaluable 
guidance, supervision, encouragement and great patience during the course of my 
research project. 
 
 I want to thank everyone in our team, Cheng Lili, Chong Mien Han, Kik Hwa Jiuan, 
Lum Tze Keong, Liang Zhian, Han Xiao, Jiang Zhaoqin, Aw Carlin Ong Siew Siang, 
Seow Hui Xian and Chua Peak Yoke for their great assistance in so many ways and the 
valuable suggestions they provided. I thank especially Augustine for his collaboration in 
the phosphorothioate project. I am also thankful for my friends, Lu Yong, Cai Liping, Pan 
Xiaoyong, Teo Tanglin, Fang Zhen, Hu Jun and Wang Chunxia. I really cherish the happy 
times that I spent with them. 
     
I am grateful to the staff members in the laboratory supplies, teaching laboratories, 
NMR and mass spectrometry laboratories in the chemistry department at NUS for their 
assistance. I am also thankful to the National University of Singapore for granting me a 
research scholarship which financed my graduate study.  
     
 Finally, I am grateful to my parents and my sister, for their love, understanding and 















      
 
In the first part of this thesis, chiral auxiliary 24 was synthesized. The novel chiral 
auxiliary 24 containing an amide functionality was easily derived from tryptophan. The 
key stereogenic center in 24 was generated by the Pictet-Spengler condensation. The 
chiral auxiliary 24 was applied in the stereoselective synthesis of phosphorothioates 
through a sequence of reactions with phosphorus trichloride and properly protected 
thymidine. However, the desired cyclic phosphoramidite could not be formed. Relevant 
model systems were then synthesized and studied, and we proposed that the neighboring 
group participation may be responsible for such failure of cyclic phosphoramidite 
formation.  
     In the second part, several proline derived organocatalysts containing thiourea 
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Chapter 1  
The Antisense Phosphorothioate Oligonucleotides 
 
1.1 The Antisense Oligonucleotides 
1.1.1 The Antisense Oligonucleotides 
Even today, new drugs are usually not discovered by rational drug design. On average, 
it is necessary to synthesize and test about 10000 new compounds in order to discover a 
new active substance worth development. In many cases the active substance is to be 
directed against proteins such as enzymes, receptors, or ion channels, the structure and 
mode of action of which are usually very complicated and often incompletely understood.  
Contrary to the traditional drug discovery approach, therapeutic intervention at the 
level of the nucleic acid appears to offer a number of advantages. On transcription, every 
gene gives rise to a relatively large number of copies of messenger ribonucleic acid 
(mRNA), which is translated into a large number of protein molecules. This is why 
inhibition of gene expression ought to be more efficient than inhibition of the resulting 
protein product. There are already a number of drugs on the market whose activity is 
based on direct interaction with deoxyribonucleic acid (DNA). Many of these compounds, 
which are mainly used for chemotherapy, intercalate or hind specifically only to DNA. If 
the recognition step, the binding to the DNA, is followed by a response, according to 
Hurley and Boyd,1 the DNA should be regarded as a receptor in the pharmacological 
sense. Classical drugs such as adriamycin, bleomycin, or cisplatin are, however, unable to 
exhaust the sequence information contained in the nucleic acids and thus do not act 
specifically on particular genes. It is, however, possible to achieve such sequence-specific 
recognition of nucleic acids using synthetic oligonucleotides that bind specifically by 
hydrogen bonding to complementary nucleic acids. These compounds are called 
antisense oligonucleotides based on their binding to the target sequence (sense strand). 
   Antisense oligonucleotides are short stretches of DNA (12–30 nucleotides that are 
complementary to a target mRNA). The Antisense oligonucleotides selectively hybridize 
to their complementary RNA by Watson-Crick base pairing rules. The translation of 
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target mRNA is inhibited by an active and/or a passive mechanism when hybridization 
occurs between the elementary helices. Passive mechanism results from the hybridization 
between the mRNA and exogenous nucleotide sequence, which leads to duplex formation 
that prevents the ribosomal complex from reading the message. In the active mechanism, 
hybridization allows for binding of RNaseH, which destroys the RNA but leaves the 
DNA oligonucleotide intact to hybridize with yet another mRNA target. 
   An additional point in favor of therapeutic use of oligonucleotides is that they occur 
endogenously in eucaryotic cells.2 Moreover, the antisense principle is also used in nature 
to regulate gene expression. In both procaryotic and eucaryotic cells there is known to be 
a natural method of regulation based on the binding of complementary nucleotide 
sequences (antisense RNA) to particular nucleic.3-7 Thus, if the nucleotide sequence of 
the target molecule is known, it is possible to write down directly the chemical formula of 
the inhibitor, corresponding to the base sequence of the antisense oligonucleotide, which 
amounts to rational drug design. Unlike rational drug design when the target molecules 
are proteins, there is no need for X-ray structure and NMR analyses. However, it ought to 
be emphasized that antisense oligonucleotides can be used not only to inhibit but also to 
activate gene expression. This is possible, for example, indirectly by suppressing the 














































Scheme 1 Watson-Crick base pairing  
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   Zamecnik and Stephenson were the first to propose, in 1978, the use of synthetic 
antisense oligonucleotides for therapeutic purposes.9, 10 These antisense oligonucleotides 
were able with a 13-mer oligonucleotide that was complementary to the RNA of Rous 
sarcoma virus to inhibit the growth of this virus in cell culture. The specific inhibition is 
based on the specific Watson-Crick base pairing (Scheme 1) between the heterocyclic 
bases of the antisense oligonucleotide and of the viral nucleic acid. The process of 
binding of the oligonucleotides to a complementary nucleic acid is called hybridization. 
Various cellular processes can be inhibited depending on where the oligonucleotide 
hybridizes on singlestranded regions of the DNA or Mrna. For the antisense 
oligonucleotide to be able to inhibit translation it must reach the interior of the cell 
unaltered. The requirements for this are, on the one hand, stability of the oligonucleotide 
toward extra- and intracellular enzymes but also, on the other hand, ability to penetrate 
through the cell membrane. Once it has reached the cytoplasm it must bind specifically 
and with sufficient affinity to the target mRNA to inhibit its translation into the 
corresponding protein. In order to meet all these requirements it is necessary for normal 
oligonucleotides to be chemically modified in a suitable manner. 
 
1.1.2 Modified Oligonucleotides 
   For the antisense oligonucleotide principle to be put into practice the nucleic acid 
derivatives employed must comply with the following requirements: (1) the complex 
formed between the oligonucleotide and its complementary target sequence must be 
sufficiently stable under physiological conditions; (2) The interaction between the 
oligonucleotide and its target sequence must be specific; (3) The oligonucleotide should 
be resistant to enzymes that degrade nucleic acids (nucleases); (4) The oligonucleotide 
must be able to pass through the cell membranes to reach its site of action. Whereas the 
requirements for specificity and binding affinity are satisfactorily met by the unmodified 
oligonucleotides, adequate stability to nucleases and sufficient passage through 
membranes can be achieved only by modification of the oligonucleotides. Thus, of course, 
purely academic interest gave rise to a variety of modifications. Essentially, all 
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constituents of the oligonucleotide chain: base, sugar, and phosphate backbone, can be 



































Scheme 2 Possibilities for modifying oligonucletides
 
   The backbone modifications such as methylphosphonate11-13 and peptide nucleic acids 
(PNA),14-19 could enhance the nuclease resistance. However, they failed to recruit RNase 
H for the target RNA cleavage. The presence of neutral backbone in these modifications 
also reduces their aqueous solubility and cellular internalization.13, 18, 20 The boranophos- 
phate modification21-23 has shown enhanced RNase H eliciting power but the low binding 
affinity to the target hampers its antisense potential. Among the numerous chemical 
modifications,24 phosphorothioate oligonucleotides have stood out as the most promising 
and advanced antisense agents. 
 
1.2 Phosphorothioate Oligonucleotides 
1.2.1 Introduction 
Advances in synthetic chemistry and molecular genetics in the past several years have 
led to new approaches towards the development of new therapeutics. These new 
approaches involve blocking genetic messages to turn off the production of 
disease-causing proteins. The target here is a nucleotide sequence on a single stranded 
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messenger RNA, which encodes for disease-causing proteins, or double stranded DNA 
from which mRNA is transcribed. Once a target sequence is determined, complementary 
or antisense DNA sequence that bind via Watson-Crick type hydrogen bonding and 
deactivate the genetic message can be synthesized. At 16-28 nucleotides long, an 
antisense oligonucleotide is expected to be highly selective in its ability to recognize and 
bind to its target sequences, since a single mismatch in the complementary strand can 
reduce the affinity for hybridization by several orders of magnitude. Unmodified 
synthetic oligonucleotides are not expected to function well as potential therapeutics 
because they are readily degraded by nucleases. Changes in the phosphodiester-sugar 
backbone, mostly by replacement of non-bridging oxygens at internucleutide phosphates, 
led to the first-generation compounds such as oligonuc1eoside methanephosphonates  
and oligonuc1eoside phosphorothioates (Scheme 3). These modifications in chemical 
structure are being evaluated for stability of oligonucleotide analogues, ability to 
permeate the cells, toxicity, and affinity to hybridize with a target mRNA. Both OligoM 


















Scheme 3    PS-Oligos  
   Phosphorothioates are among the most obvious and thus probably earliest used 
analogues of naturally occurring phosphates.25 For example, the antiviral effect of 
thiophosphate-substituted polyribonucleotides was described back in 1970 by De Clercq 
and Eckstein.26 The original observation of increased stability of dialkyl (aryl) phosphor- 
othioates towards nucleases became the basis for the application of oligonucleotide 
phosphorothioates in modulation of gene expression, as successfully demonstrated by 
Matsukura et al. and Agrawal et al.31  
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   It has also been demonstrated recently that double-stranded phosphorothioate 
oligonucleotides are able to accumulate in cells more effectively than native 
double-stranded oligonucleotides, and to modulate gene expression in a specific manner, 
most probably by competition for binding of specific transcription factors, and in this 
way may provide antiviral, immunosuppressive, or other therapeutic effects. 
In phosphorothioate oligodeoxynucleotides, one of the phosphate oxygen atoms not 
involved in the bridge is replaced by a sulfur atom, with the negative charge being 
distributed unsymmetrically and located mainly on sulfur.27, 28 Thus, PS-Oligos possess 
polydiastereomeric phosphorus centers (Scheme 4). This substitution results in properties 
such as stability to nucleases, retention of solubility in water, and stability to 

















 Scheme 4  Stereochemistry of PS-Oligos  
1.2.2 Nonstereocontrolled Synthesis of Oligonucleoside phosphorothioates 
   Oligonucleoside phosphorothioates have been prepared until now by primarily two 
methodologies: A) stepwise phosphoroamidite coupling followed by sulfurization of the 
intermediate O-alkylphosphite 5; B) tandem sulfurization of oligonuc1eoside 
H-phosphonates bound to the solid support. (Scheme 5) 
A) The Phosphoramidite Method 
   The synthesis of the PS-Oligos via the phosphoramidite approach was first reported 
by Stec et al.29 Later, Matsukura et al.30 reported an improved version of this method. The 
method was based on the reaction of the 5’-hydroxy group of a polymer-supported 
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growing DNA chain 2 with a nucleoside cyanoethyl N, N-diisopropyl-phosphoramidite 4, 
catalyzed by 1H-tetrzaole to provide phosphite triester 5, followed by (1) sulfiuization, (2) 
capping of the unreacted 5’-OH group, (3) removal of the 5’-trityl group, (4) 
condensation with 2/tetrazole and (5) the steps (1) - (4) are repeated n times to provide 
the final product PS-Oligos (Scheme 5). 
B) The H-Phosphonate Method 
   The advent of practical, automated H-phosphonate chemistry for DNA synthesis, 
which was first extended by Froehler to phosphorothioate analogue, provided for the use 
of an attractive one-step sulfurization reaction that could be easily and safely performed 
manually. The starting material of this method involves 5’-O-DMT-nucleoside-3’-O-H- 
phosphonates 4, which was activated by trimethylacetyl (pivaloyl) chloride or 
adamantoyl chloride and reacted with 1 to give O, O-diaikyl-H-phosphonate 6. This is 
followed by (1) removal of the 5’-trityl group, (2) condensation with 4/pivaloyl or 
adamantoyl chloride and (3) capping of the unreacted 5’-OH group. (4) Steps (a)-(c) are 
repeated n times, followed by (5) final sulfurization to provide the PS-Oligos (Scheme 5). 
The key feature of the H-phosphonate approach to PS-Oligos is the one-step and very 
efficient sulfurization. However, the H-phosphonate method has significantly lower 
coupling efficiency (ca. 95 %) than the phosphoramidite method (ca. 99%). 
   Assuming that both H-phosphonate and phosphoramidite methodologies are neither 
stereospecific nor stereoselective and that each O-alkyl phosphite internucleotide bond or 
each H-phosphonate bond is formed in a nonstercoselective manner, the resulting Oligo-S 
consists of a mixture of 2n diastereomers, where n is the number of phosphorothioate 
internucleotide bonds. However, it should be noted that among the Rp and Sp 
diastereomers, only the Sp isomer is nuclease resistant. Recent in vitro studies showed 
that the properties of PS-Oligos, such as binding affinity, stability to nucleases and 
RNase H activity were affected by the configurations at the phosphorus atoms. Therefore, 
Practical methods for the preparation of PS-Oligos with well-defined stereochemistry at 




















































Scheme 5 Synthesis of oligonucleoside phosphothioates with the phosphoroamidite method (A) and 
H-phosphondte method (B). A) 1. Sulfurization. 2. Capping of the unreacted 5’-OH group. 3. Removal 
of the 5’-trityl group.  4. Condensation with 2/tetrazole. 5 steps 1-4 are repeated n times. B) 1. 
Removal of the 5’-trityl group. 2. Condensation with 4/pivaloyl (adamanroyl) chloride, 3. Capping of 
the unreacted 5’-OH group. 4. Steps 1-3 are repeated n times. 5. Final sulfurization. For both methods 
the product is then cleaved from the solid support, deprotected, and purified. R1 = CH2CH2CN. Me: R2 
= long chain amine controlled pore glass (LCA-CPG); B1, B2 = AdeBz, GuaiBu, CytBz, Thy. 
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1.3 Sterecontrolled Synthesis of Oligonucleoside Phosphorothioates    
Phosphorothioate oligonucleotides prepared by currently available technology are 
consist of a mixture of 2n diastereoisomers, where n is the number of P-chiral 
phosphorothioate centers. Unfortunately, there are no available analytical tools for direct 
measurement of the reproducibility of preparing a diastereoisomeric population of 
phosphorothioate oligonucleotides when n>3. Since phosphorothioate oligonucleotides 
are used in concentrations several-to-many orders of magnitude higher than their targets 
such as mRNA (when applied in an antisense manner) or regulatory proteins, one may 
assume that a target ‘selects’ the most appropriate population of diastereoisomers with 
regard to the chirality of phosphorothioate linkages. On the other hand, documented 
stereoselectivity of some nucleases towards dinucleoside (3’, 5’) phosphorothioates (1) 
suggests that stereocontrolled synthesis of phosphorothioate oligonucleotides with 
predetermined chirality at each P-stereogenic center might allow one to obtain certain 
diastereoisomers which are most resistant towards nucleolytic enzymes, thus increasing 
their life-time, and in this way decreasing the required amount of xenobiotic material for 
a given therapeutic effect. In addition to this practical aspect, stereo-defined 
phosphorothioate oligonucleotides could become uniquely informative tools for studies 
of mechanisms of their interaction with target macromolecules, and, in theory, their 
stereodifferentiated cell-uptake and, distribution, and metabolism can also be considered. 
 
1.3.1 Nucleophilic Displacements at Tetracoordinate Phosphorus Centers  
1. 3.1.1 Stereoselective Nucleophilic Substitution at Tetracoordinate Phosphorus 
Centers 
The most promising and straightforward approach to stereocontrolled synthesis of 
Oligo-S involves substrates 7 bearing leaving group L (R2 = aryl, X = O, Y = S or R2 = 
alkyl, X = S, Y = O; Scheme 6), which in the process of nucleophilic substitution at the 
phosphorus atom can be replaced by the 5’-OH function of the nucleoside or 







R1=DMT, pixyl. etc; R2=alkyl, aryl; X,Y= S,O
B1=protected Ade, Gua, Cyt, Thy;
L=leaving group
7





Such substrates 7 (R2X = MeS, Y=O, L=4-NO2C6H4O) were first described by 
Lesnikowski et al.31 The separated diastereomers of 7 reacted with 3’-O-acetyl 
nucleosides in the presence of tBuMgCl to give dinucleoside 3’, 5’-(s-methyl)phosphoro- 
thioates 8 (Scheme 7). Cleavage of the CH3-S bond (phosphorothioate deprotection) was 
achieved in a later step with PhSH/Et3N. The coupling occurs with inversion of 
configuration at phosphorus with a stereospecificity of > 95% and furnishes d[TpsT] in 















    Scheme 7. Stereospecific nuclephilic substitution at the phosphorus 
center in 7. This reaction is used for the synthesis of short oligo-s














Although this methodology cannot be used in solid-phase synthesis, Lesnikowski et 
al.31 were able to demonstrate that preparation of stereochemically pure trimers d 
[TpsTpsT] and tetramers d[TpsTpsTpsT] is feasible if protective groups such as 
4-chlorobenzyl are introduced at sulfur. This strategy was applied to the synthesis of (Rp, 
Rp)-and (Sp, Sp)-UpsUpsU.31 In spite of efforts to find other catalysts, tBuMgC1, which 
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was introduced for oligonucleotide chemistry by Hayakawa et al.32 is the catalyst of 
choice; other catalysts such as tBuOK, DMAP, and DBU gave unsatisfactory yields or 
led to P-epimerization.33 
 
1.3.1.2 The Oxathiaphospholane method  
   In 1995, Stec et al proposed a novel strategy leading to stereodefined Oligo-S based 








































9  a-d: R=H,   X=S
10:a-d  R=Me, X=S
11:a     R=H,   X=Se
12:       R-R=-(C2H5)-
 Scheme 8  Oxathiaphospholane method
n
: Solid Support




   In the oxathiaphospholane method, the starting oxathiaphospholanes 9, 10, 11 or 12 
were prepared as a pair of diastereomers, which were then separated by careful silica gel 
column chromatography. Each isomer was reacted with nucleoside 13 which was bound 
to the solid support at the 3’-position. Intermediates 14 were formed accordingly. 
Subsequently spontaneous loss of episulfide led to the formation of the internucleotide 
phosphorothioate function in over 95% yield and over 98% diastereomeric excess (de). 
 18
After repetition of the coupling cycles, stereochemically well-defined PS-Oligos could be 
prepared. 
   The oxathiaphospholane approach is the only method currently available to allow for 
the stereocontrolled synthesis of PS-Oligos with a 16-28 base length, which is required 
for the applications in antisense strategy. The applications and various aspects of 
oxathiaphospholane approach have been extensively reviewed by Stec and co-workers in 
a number of excellent reviews.35-37 However, this ingenious method suffers from some 
drawbacks. A serious problem is the difficulty associated with the separation of 
diastereomerically pure phospholane starting materials. Such column chromatographic 
separation on silica gel was difficult and tedious.38, 39 Even though Stec et al. were able to 
achieve relatively easy separation of monomers in their latest improved system,40 it does 
not seem ideal and practical that such column separation can be adapted to the large scale, 
routine preparation of PS-Oligos. In addition, the condensation step required a large 
excess of 1, 8-diazabicyclo [5, 4, 0] undec-7-ene (DBU) and precursors. The combination 
of the above made this method not applicable to large scale preparations in a practical 
sense. 
1.3.1.3 Diastereoselective Activation of Prochiral Substrates with Tetracoordinate 
Phosphorus Centers   
The P-prochiral substrates 15 (Scheme 9) are employed in the phosphotriester 
approach to oligonucleotide synthesis.41 When R2X was an alkoxy or aryloxy group, 
activation of phosphate function led to the formation of P-chiral dinucleoside 3’, 
5’-O-aryl(alkyl)phosphates. Since the synthesis requires the subsequent removal of the 
O-aryl function, the diastereomeric ratio of the intermediate triester was not of interest. 
However, the prochirality of 15 suggests that the activation process could be 
diastereoselective. Indeed, in one well-documented case, Ohtsuka et al.42 proved that the 
condensation of N6, 5’-O-bis-(dimethoxytrity1)adenosine 3’-O-[(O-2-Chloro-phenyl)- 
phosphate] with N6, 3’-O-bis(dimethoxytrityl)adenosine in the presence of 1 -(2, 4, 6- 
triisopro-pylbenzenesulfonyl)-5-(pyridin-2-yl) tetrazole as the activating agent gives, 
after deprotection, dideoxyadenosine 3’, 5’-O-(2-chlorophenyl) phosphate with (Sp) 
configuration. This particular finding prompted Cosstick and Williams43 to study the 
diastereoselective activation of 16 (B1 = CytBz; Scheme 10). They demonstrated that 
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reaction of 16 with 3’-O-acetylthymidine in the presence of 17 leads to the formation of 
the corresponding dinucleoside 20, which after decyanoethylation at sulfur consists of the 
diastereomeric mixture of d[CpsT] with a distinctive preponderance of the Sp 
diastereomer. In the best case the ratio of diastereomers Sp:Rp was 79:21. Such 
enrichment, although not satisfactory in terms of a stereocontrolled synthesis of 
PS-Oligos, is worth deeper consideration and perhaps more extensive study. If the 
mechanism of activation of 16 involves stereoselective formation of the mixed 
phosphorothioic sulfonic anhydride 18, and this undergoes double nucleophilic 
substitutions (first by 17 with transient formation of phosphorotetrazolidate 19 and 
subsequent reaction with 3’-O-acetylthymidine to give phosphorothioate triesters 20), 
attempts at introducing sterically demanding protective groups on nucleobases and 
hydroxyl functions not participating in the coupling process increase the probability of 
diastereoselective formation of dinucleoside 3’, 3-phosphorothioates. This promising 
scenario must be taken with caution, because earlier studies of Knorre, Zarytova. et al. 
indicated that the phosphorylating intermediates in the triester approach to 
oligonucleotide synthesis are pyrophosphates;44 their intermediacy and the possibility of 
equilibration at the phosphorus stereocenter may cancel the effects of diastereoselective 











Scheme 9. R1=DMT, pixyl.etc.; R2=alkyl, aryl;



















































Scheme 10 Diastereoselective activation of P-prochiral phosphorothioate 16 




1.3.2 Stereoselective Formation and Sulfurization of Oligonuc1eoside 
H-phosphonates         
The H-phosphonate approach to oligonucleotide synthesis involves 
5’-O-DMT-nucleoside 3’-O-H-phosphonates as P-prochiral substrates. Their activation 
with sterically demanding pivaloyl46a or adamantoyl46b chloride may, in principle, be 
stereoselective and lead to chiral oligonuc1eoside H-phosphonates bound to the solid 
support. These, after tandem sulfurization, cleavage from the support, and nucleobase 
deprotection, give Oligo-S.47  
   Hata et al.48 found that degradation of dinucleoside 3’, 5’-α -ketophosphonates 21 by 
































Scheme 11 The DBU-catalyzed aminolysis of phosphonates 21 was
remarkably diastereoselective, as shown by the diastereomeric ratio
of the sulfurized product. a) 1. S8. 2. deprotection of OH groups.
b ) 1. deprotection of OH groups 2. Me3SiCl/ Et3N+ S8, B1=Ade , Thy;
B2=Thy; Ar=phenyl, p-chlorophenyl  
 
   In these studies intermediate H-phosphonates 22 were not isolated but treated with 
trimethylsilyl chloride and sulfurized with elemental sulfur. Depending on the kind of 
protective groups and the sequence of deprotection/sulfurization steps, either pure 
(Rp)-dinucleoside 3’, 5’-phosphorothioate or a significantly enriched mixture of 
diastereomers [(Sp):(Rp) = 2.5:1] was obtained. As pointed out in the case of d(TpsT), 
when a benzoyl or tert-butyldimethylsilyl group was used as the 3’-terminal protecting 
group instead of 1, 3-benzodithiol-2-yl (DBT), the formation of the phosphorothioates 
was not stereoselective. Because the starting a-ketophosphonates 21 were used as a 
mixture of diastereomers for the DBU-catalyzed aminolysis, the conclusion drawn was 
that DBU influences the configurational equilibration of the resulting H-phosphonates. 
Hata et al. postulated that DBU, generally considered to be a nonnucleophilic base,48 
interacts with H phosphonates to form pentacoordinated intermediates which epimerize at 
the phosphorus center by pseudorotation to give the thermodynamically more stable 
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isomers. The thermodynamic preference is dictated by steric demands of bulky ligands 
(augmented by sterically demanding protecting groups at the 5’-O and 3’-O positions). 
   A different explanation must be given for the stereoselectivity in the synthesis of 2, 
5’-(ApsA) reported by Battistini et al.49 Condensation of Nb-benzoyl -3’, 5’-O, O-Tetrais- 
opropyldisiloxane adenosine 2’-O-(H-phosphonate) 23 with 24 in the presence of 
pivaloyl chloride provides exclusively (Sp)-configurated diadenosine 2’, 5’-phosphorothi- 
oate 25 after sulfurization.(Scheme 12). The interpretation of this result was the presence 
of sterically demanding protective groups at the nucleoside components. Presumably, for 
steric reasons, acylation of anionic 23 occured exclusively at the pro-R oxygen atom, and 
anhydride 26 reacted stereospecifically with 24 leading to Rp-2’, 5’-APHA 27. 
Subsequent stereoretentive sulfurization gave Sp-25 (Scheme 13). In both H-phosphonate 
approaches presented above, the synthesis of phosphorothioate dimers was highly 
diastereoselective. However, it did not seem to be applicable to the synthesis of longer 























































Scheme 13 (pro-R)-O-AcyIation of 23 responsible for the diastereoselective synthesis of 2’, 5’-ApsA.
23 26 27 25
(Rp)-2’, 5’-APSA (Sp)-2’, 5’-APSA
 
 
1.3.3 Nucleophilic Substitution at Tricoordinate Phosphorus Centers    
Stereoselective syntheses of Oligonucleoside phosphorothioates utilizing substrates 
28 (Scheme 14), which contain a tricoordinate phosphorus center (PIII), have the 
following limitations: substrate 26 must be separable into its P enantiomers; the R1 group 
must be an acid-labile protecting group; X must be an oxygen or sulfur atom, and R2 
should be removable by cleavage of the X-R2 bond. If R2X = L, prochiral 28 offers the 







R1=DMT, pixyl. etc; R2=alkyl, aryl; X= S,O or
R2X=Me; B1=protected Ade, Gua, Cyt, Thy;
L=leaving group
28
    Scheme  14  
 
In early attempts at the diastereoselective synthesis of Oligonucleoside 
phosphorothioates56substrates 28 (R1= DMT. R2X = MeO, L = iPr2N, B1=CytBz) were 
obtained in diastereomerically pure form, but their activation by tetrazole appeared to 
cause P-epimerization. Besides protonation, activation of 28 by tetrazole also involves 
the substitution of the NiPr2 group by tetrazole. Intermediate phosphorotetrazolidites 29 
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undergo fast P-epimerization in the presence of an excess of tetrazole, most probably by 





























(Rp)- d (CpsC) + (Sp) d(CPSC)
30
Scheme 15 Diastereomerically pure 28 undergoes P-epimerization in the presence of tetrazole , which impedes the 
stereocontrolled synthesis of PS-Oligos by phosphoroamidite methodology. a) 1. S8 ; 2. deprotection R1=DMT; R2=Me; 
R3=LCA-CPG; B1=B2=CytBz  
      
   Selectivity may also be attained by the diastereoselective reactions of prochiral PIII 
substrates (28, R2X = L) with the 5’-OH function of the nucleoside component. 
Diastereoselectivity within the coupling process is possible since both reagents (3’-O- 
phosphitylated nucleoside and 5’-OH nucleoside) bear chiral auxiliaries (2’-deoxyribosyl 
moieties), and one of the two competing routes (leading to the (SP) and (RP) 
diastereomers) can be considered to be kinetically favored. In the course of the 
development of the phosphorodiamidite approach to oligonucleotide synthesis,50 
5’-O-DMT-thymidine 3’-O-phosphorodimorpholidite 32 was synthesized and coupled 













































Scheme 16   The synthesis of Oligo-S with the phosphoroamidite method could 
not be conducted diastereoselectively. R1=DMT; R3=Ac, B1, B2=Thy, (Rp)-/(Sp)-




Unfortunately, neither phosphorothioate 34 nor H-phosphonate 35 were enriched in one 
diastereomer to a meaningful extent.51 These results strengthen the hypothesis that any 
phosphoroamidite substrate like 28, which is activated by an acid nucleophilic catalyst, is 
prone to P-epimerization. In order to reduce P-epimerization, Iyer et al.52 used the 
phosphoramidite synthons of type 37 into which chiral auxiliaries were incorporated to 
replace the most common nucleoside β-cyanoethyl phosphoramidite 36 in the synthesis 
of phosphorothioates. Synthons 38 and 39 were the earlier ones employed in their 
synthesis.52, 53 However, even phosphoramidite 39 was obtained as a single diastereomer, 
the subsequent solid phase synthesis employing 39 did not generate phosphorothioate 





































   In a later improvement, Agrawal and coworkers employed a bicyclic oxazaphospholi- 
dine 38 for the solid phase synthesis of phosphorothioates.54 The bicyclic structure was 
designed to provide more conformational restriction to limit the pseudo rotation which 
was believed to result in the P-epimerization during the coupling reaction of 
phosphoramidite 39. The bicyclic oxazaphospholidine 41 was easily derived from 
L-prolinol. The intermediate P-chloro-oxazaphospholidine 40 was obtained as a single 
stereoisomer, which was then further converted to bicyclic oxazaphospholidine 40 as a 
single diastereomer, as revealed by 31P NMR (Scheme 18). Chirally pure 41 was 
subjected to the routine solid phase synthesis of dimeric phosphorothioates. After 
tetrazole-mediated coupling reaction with controlled pore glass (CPG)-bound nucleoside 
and sulfurization, the thymidine-thymidine dinculeotide phosphorothioates (TPST) was 
obtained in a greater than 90% diastereoselectivity upon cleavage from the solid support. 
Recently, this methodology was extended to the preparation of stereo-enriched 



















Scheme 18 The bicyclic oxazaphospholidine synthon  
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Chapter 2 Recoverable Chiral Auxiliary for the 
Stereo-controlled Preparation of Oligonucleoside 
Phosphorothioates      
 
2.1 Introduction    
The effect of oligonucleotide phosphorothioates (PS-Oligos) as antisense inhibitors of 
gene expression is well recognized,1 and their therapeutic potential has been 
demonstrated in clinical trials against AIDS and cancer.2 The PS-Oligos currently 
employed in clinical studies and biological evaluations are obtained as mixtures of 2n 
diastereomers, where n is equal to the number of internucleotidic phosphorothioate 
linkages. 
   Clearly, additional studies, using stereodefined oligonucleoside phosphorothioates, 
are warranted to gain further insights on the impact of P-stereoselectivity on antisense 
activity, both in in vitro, and in in vivo systems. For this purpose, a practical synthetic 
approach is required that would provide access to stereopure Rp or Sp phosphorothioate 
oligonucleotides. Recently, two promising methods have been reported. In the first report, 
Stec and coworkers used nucleoside oxathiaphospholane building blocks to prepare short 
stereoselective phosphorothioates.3 Wang and Just showed that nucleoside 
indoloxazaphosphorine synthon can be used to prepare stereopure dinucleoside 
phosphorothioates.4 However, their methods suffer from the fact that the chiral precursors 
have to be separated chromatographically and none of them provides a practical solution 
to the large-scale stereoselective preparation of PS-Oligos. Therefore, there still exists a 
need to develop practical stereoselective syntheses of PS-Oligos. 
 
2.2 The objective of the Research 
2.2.1 The Phosphoramidite Approach 
The phosphoramidite method to the non-stereocontrolled synthesis of PS-Oligos was 
well established and very efficient. It seemed therefore very important to modify it to 
prepare chiral PS-Oligos, rather than developing a new technology. The classical 
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phosphoramidite method leads to PS-Oligos with no control of stereochemistry on the 
phosphorus atom because the substitution is done on a diastereomeric mixture of 
phosphoramidite. Therefore, it was first thought that the diastereomerically pure 
phosphoramidite 1 would lead to a phosphite triester 3 with a well defined sense of 
chirality on the phosphorus atom, followed by stereoretentive sulfurization to give the 
P-chiral phosphorothioate. However, a diastereomer mixture of phosphite triester 3 was 
obtained because of the P-epimerization at the phosphorus atom (Scheme 1).5 Detailed 
mechanistic studies confirmed this mechanism.6, 7, 8 Besides protonation, activation of 1 
by tetrazole also involved the substitution of the diisopropylamino group by tetrazole. 
Intermediate phosphorotetrazolidites 4 undergo fast P-epimerization in the presence of an 
excess of tetrazole, most probably by rapid exchange of substituents. Eventually, the 
phosphite trimester 3 was obtained as a mixture of two diastereomers and the 
stereoselectivity was completely lost, constituting the reason why the phosphoramidite 
































































2.2.2 The Stereoselective Synthesis of Phosphorothioates by Using the 
Phosphoramidite Approach 
   In order to adapt the phosphoramidite approach to a stereocontrolled synthesis of 
phosphite triesters, and therefore phosphorothioates, two essential requirements had to be 
met. The first one is to access chirally pure phosphoramidites without tedious separation 
of diastereomers, and the second issue is to transform the above diastereomerically pure 
phosphoramidites into phosphate triesters in a stereospecific manner. Among the various 
approaches reported to tackle these issues, the stereoselective method initiated by Just et 
al.9 has progressed considerably.  
   Wang et al investigated indole moiety as a leaving group for the synthesis of 
phosphorothioates (Scheme 2).10 When compound 5a was treated with phosphorus 
trichloride, phosphorochloridites 2 were obtained as a mixture of isomers, in which 
probably compound 6ax predominated. The subsequent in-situ reactions with T3’OH at 
room temperature gave phosphoramidites 7 as a pair of diastereomers in a ratio of 7 to 1. 
When a mixture of isomers of compound 6 were subjected to the DBU-promoted 
coupling reactions with T5’OH, two isomers showed markedly different reactivities. The 
major diastereomer 8eq reacted much faster than the minor isomer 8ax. When the 
reaction of compound 8eq was completed, compound 8ax almost did not react. After 
filtering off DBU with a short column and treatment with Beaucage’s reagent, 
phosphorothioate 9-SP was obtained with a 97% de. However, the chiral auxiliary could 
not be removed by treatment with concentrated ammonia. In a later refinement10 in which 
chiral auxiliary 5b was employed, reactions were carried out similarly with about the 
same diastereoselectivity. Chiral auxiliary bearing a β-cyano group could be easily 
released by standard protocols in the end of synthesis. The cyano 
indolo-oxazaphosphorine method was applied to the solid phase synthesis of PS-Oligos. 
Unfortunately, the application was unsuccessful since the use of a large excess of DBU 
during the solid phase synthesis led to the formation of alkylphosphonates via a, β- 
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2.2.3 The Objective of the Research 
 
 In order to adapt indolo-oxazaphosphorine method to solid phase synthesis of 
PS-Oligos, Lu et al. envisaged that a more rigid structure of type 10 would be more 
efficient for the formation of cyclic phosphoramidite.12 In addition, the elimination of 
troublesome β-cyano group, in combination with the readily availability of such chiral 
auxiliaries from natural amino acids made such approach more attractive and practical 








































































             Scheme 3  The Indolo-oxazaposphorines Derived from Tryptophan  
 
   Chiral auxiliary 11 was easily prepared from L-tryptophan. When auxiliary 11 was 
treated with phosphorus trichloride, phosphorochloridite 12 existing as a single 
diastereomeric form was observed after equilibration at 50 °C. When the intermediate 12 
was further reacted with T3’OH, phosphoramidite 13 was found to be a single isomer at 
room temperature, no equilibration was necessary. Passing through a column on silica gel 
afforded pure compound 13 as a single isomer. DBU-promoted coupling reaction with 
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T5’OH transformed 13 in a stereospecific manner to diastereomerically pure phosphite 
triester 14. After obtaining phosphorothioates 15, standard treatment with concentrated 
ammonia at 55 °C allowed for the removal of chiral auxiliary and dithymidine 
phosphorothioate 16-RP was obtained with 95% de. This methodology was applied on 
solid phase for validation, both isomers of dithymidine phosphorothioates were 
satisfactorily prepared. However, the removed auxiliary cannot be reused or recycled. 
  Although the six-membered cyclic phosphoramidite approach utilizing various 
auxiliaries has shown potential application in the stereoselective synthesis of 
phosphorothioates, much improvement is still required to adapt this methodology to the 
routine solid phase synthesis of PS-Oligos. One important practical aspect lies with the 
use of the chiral auxiliary. The chiral auxiliary not only needs to be efficient in the 
diastereomeric induction. It also should be easily accessed at low cost. Thus, it would be 
highly favorable and economical if one could recover or reuse the auxiliary.  
  However, till date, a reusable auxiliary which can induce high stereoselectivity in the 
synthesis of phosphorothioates has not been reported. As such, in this study, we hope to 
prepare a new type of recoverable or reusable chiral auxiliary which can enable efficient 
and practical synthesis of phosphorothioate dimer with high stereoselectivity in solution 
phase. 
    Considering the recovery of the chiral auxiliary at the end of synthesis, we reasoned 
that the chiral auxiliary 17 with an amide group would be more likely recoverable than 
(Scheme 4) chiral auxiliary 11. The starting material tryptophan necessary to synthesize 
the chiral auxiliary 17 is inexpensive, and readily available as both enantiomers. 
Therefore, with these chiral auxiliaries 17 and 18, different configuration (RP or SP, 












































Scheme 4  Chiral Auxiliary  
 
In our proposed synthetic plan (Scheme 5), the utilization of Pictet-Spengler 
reaction13 would install the newly formed C-1 stereospecifically. Reacting chiral 
auxiliary with phosphorus trichloride, followed by 5’-O-TBS-thymidine (T3’OH) would 
yield cyclic phosphoramidte, which can be equilibrated to give a thermodynamically 
more stable isomer. The displacement of indole moiety and sulfurization process using 
Beaucage’s reagent14 is known to be stereospecific processes. With the neighboring 
amide function properly installed, it is anticipated15 that amide participation would 
release the thymidine dime and yield a species of type 29, which upon treatment with 





























































































This novel chiral auxiliary is anticipated to possess the following interesting features: 
efficiency in chiral induction, since its structure resembles the similar chiral auxiliary 11, 
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the efficiency of which has been demonstrated; flexibility, the rate of the amide 
participation can be tuned by varying the carbon atom number between the Nb and the 
carbonyl of amide function or by changing the amide moiety of the amide function; 




2.3 Results and Discussion 
2.3.1 The Synthesis of Chiral Auxiliary 24     
  










































L-Tryptophan methyl ester hydrochloride 19 was first converted into Nb-benzyl 
L-tryptophan methyl ester 20
16 
via direct reductive amination. The Pictet-Spengler 
condensation17
 
of Nb-benzyl L-tryptophan methyl ester 20 with (tert-butyldimethyl- 
silyloxy) acetaldehyde in refluxing toluene generated compound 22 with a new chiral 
center C-1 in a highly stereoselective manner. Removal of the hydroxyl and amino 
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protecting groups in compound 22 provided compound 23. The neighboring amide 
moiety was incorporated via nucleophilic SN2 reactions to furnish chiral auxiliary 24.  
 
2.3.2. The Pictet-Spengler condensation  
The Pictet-Spengler condensation is crucial for obtaining a diastereopure tricyclic 
product. The Nb-benzyl unit introduced in the first step not only served as an amino 
protecting group but also played a part in directing the stereospecificity of the 
condensation reaction.  
  The mechanism of the Pictet-Spengler condensation is characterized by the formation 
of an iminium intermediate 32 after the acid catalyzed reaction of a tryptamine derivative 
and an aldehyde (Scheme 7). However, this iminium ion may be attacked 
intramolecularly by the electrons of the pyrrole ring, either from C-2 or C-3. Employing 
isotopic labeling, Bailey17proved that the spiro-indolenine 33, which is formed after 
attack from the indole C-3 position, may be a reaction intermediate, despite MNDO 
calculation results which have indicated that the rearrangement from 33 to intermediate 
34 is energetically unfavorable. An alternative pathway, consisting in the direct attack 
from the C-2 position (32→34), is considered by many authors as the most plausible key 







































                   Scheme 7  Mechanism of Picket-Spengler Condensation  
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Cook et al. had shown that the Pictet-Spengler condensation of Nb-benzyl tryptophan 
methyl ester with sterically bulky aldehyde in non-acidic aprotic media led to the 
stereospecific formation of the trans-1, 3-disubstituted diastereomer Indeed, the use of 
(tert-butyldimethylsilyloxy) acetaldehyde which contained a relatively bulky silyl 
substituent led to the desirable formation of the thermodynamically more stable 
trans-diastereomer as the major product (at least 80% judging from TLC) However, one 
major drawback encountered in this reaction lies in the difficult chromatographic 
separation of the cis- and trans- diastereomers (i.e. Rf difference of 0.03 in 30:1 
Hexane/EtOAc eluent system). Two rounds of purification afforded a total yield of 61%. 
Nonetheless, compound 34 remained as a versatile key intermediate in this synthetic 
scheme. 
 
2.3.3 Model studies 
   The first key issue needed to be addressed is whether the six-membered ring will be 
formed when such an auxiliary reacts with phosphorus trichloride.  
   Freshly distilled phosphorus trichloride (PCl3) was added to a solution of auxiliary 24 
in 2.2 equivalents of triethylamine (Et3N) and dichloromethane (CH2Cl2) at 0 °C. 
Evolution of white fumes was observed. The Et3N would react with the evolved HCl to 
form ammonium hydrochloride salt. Due to sensitivity to air oxidation and hydrolysis, the 
unstable cyclic phosphorochloridite 25 was not isolated and the next step was carried out 
in situ. After stirring the reaction mixture for 20 minutes, a solution of T3’OH in Et3N and 
CH2Cl2 was added at 0 °C and the resulting mixture was refluxed overnight (Scheme 8). 


























Actually, Lu et al.12 showed that when intermediate b was treated with 
5’-O-TBDMS-thymidine (T3’OH) in the presence of triethylamine in dichlomethane, the 








































Compound a could successfully afford phosphoramidites while auxiliary 24 could not 
form phosphoramidite when it was treated with phosphorous trichloride under the same 
reaction conditions. Therefore, a thorough investigation of their structural difference is 
necessary. As shown in Figure 1, the auxiliary 24 and compound a both have the same 
backbone A. But the backbone of compound a was attached to an amide group in C-3 
position while the backbone of auxiliary 24 was attached to an ester group in C-3 position. 
Besides, Benzyl group was connected to the backbone of compound a in N-2 position. 
While an amide group was connected to the backbone of auxiliary 24 in N-2 position. 
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2.3.3.1 Esterification  
   One possible reason is that ester group in C-3 in auxiliary 24 was probably 
hydrolyzed during the reaction. When phosphorus trichloride was added, lactone was 
































Scheme 10  
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However, it is unlikely that the ester group in chiral auxiliary would get hydrolyzed in 
our reaction conditions. We therefore synthesized a model compound to test the 
feasibility of the proposition of esterification. 
   Chiral auxiliary 35 was synthesized and used to evaluate the feasibility of 
esterification and the formation of cyclic phosphoramidite 16. Auxiliary 35 has the same 
backbone as auxiliary 24 except that benzyl group was attached in N-2 position (Figure 
2). Auxiliary 35 can be obtained quantitatively through the removal of the silyl protecting 































A model reaction with 35 is shown in Scheme 13. A solution of compound 35 in Et3N 
and CH2Cl2 was transferred slowly to a NMR tube containing PCl3 in CH2Cl2 at 0 °C. 
After about 15 minutes, the NMR tube was sealed with an air-tight cap. 31P NMR 
examination of the crude mixture revealed several signals from 145 to 115 ppm as well as 
the resonance due to PCl3. The mixture was heated at 50 °C and 31P NMR analysis was 
performed occasionally. The signal due to PCl3 (i.e. 220 ppm) gradually shortened while 
a signal at 143.6 ppm grew. After 24 hours of heating, a major resonance at 143.6 ppm 
persisted. As no further intensity change was observed, the reaction mixture was cooled 
and a solution of T3’OH in Et3N and CH2Cl2 was added at 0 ºC. Thirty minutes later, a 
major signal at 118.0 ppm was observed. Since no prominent resonance was observed 
around 0 ppm, there is negligible amount of hydrolyzed product. The signals at 143.6 
ppm and 118.0 ppm corresponded to a single diastereomer of cyclic phosphorochloridite 
36 and phosphoramidite 37, respectively.12 Hence, model reaction showed the successful 
formation of phosphoramidite using modified auxiliary 35. In this experiment, ester 
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group in auxiliary 35 did not hydrolyze. Therefore, the proposition of failure of formation 



































Scheme 13  Synthesis and Testing of Auxilairy  35.  (a) TBAF, THF; 
(b) PCl3, Et3N, CH2Cl2.TBAF=tetrabutylammonium fluoride  
 
Synthesis of phosphoramidite 26 was attempted again and it followed the exact 
experimental conditions (heating time etc.) as established from the formation of 
phosphoramidite 37. However, the reaction cannot be conveniently carried out in a NMR 
tube due to poor solubility of auxiliary 24 in CH2Cl2 and other suitable solvents such as 
THF and MeCN. Instead, a Schlenk flask was used. Despite the change in experimental 
condition and more stringent control on handling of apparatus and reagents (scrupulously 
dried apparatus and syringe etc.), the reaction did not proceed as desired. No significant 
differences in the experimental results were detected compared with the previous trials.  
   Auxiliaries 24 and 35 have the exact backbone framework (Figure 2). However, 
diastereoselective formation of cyclic phosphoramidite is only possible with auxiliary 35. 
We suspect that result may be due to the replacement of benzyl group with amide group.  
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   It suggested that the amide moiety could have caused some form of complication that 
interfered with the formation of cyclic phosphoramidite. Attempts to isolate the side 
products remained futile.  
 
 
2.3.3.2 Neighbouring group participation 
The unsuccessful formation of tetracyclic phosphorus intermediates was suspected to 
be caused by neighbouring group participation. Neighbouring group participation is well 
documented as far as the mechanism and scope of the reaction are concerned.19 
Neighbouring-group effects have been found to be responsible, for example, for the 
regioselective and diastereoselective alkylation of diketones20a and for the reaction of 
α-acetoxy carboxylic acid chlorides, or their corresponding gluconic acid chlorides, with 
hydroperoxides, yielding 2-alkylperoxy-1, 3-dioxolan-4-ones instead of the expected 
esters.20b, 20c Similarly, the reaction of γ-keto-acid chlorides and o-aroylbenzoyl chlorides 
with hydroperoxides delivered heterocyclic peroxides.20d Ribonucleoside phosphodichlo- 
ridate, with a free cis-vicinal hydroxy group, shows a definite rate enhancement upon 
alcoholysis relative to the cis unsubstituted compounds.20e, 20f Also, N-acyl functions have 
been shown to promote the conversion of nitriles into carboxamides under mild 
conditions by a neighbouring-group effect.20g
   Neighbouring group participation
17, 21
may arise as shown in Scheme 14. The 
intramolecular nucleophilic displacement by the amide moiety can take place via oxygen 
or nitrogen although N-attack is less likely. In Scheme (a), the participation is promoted 
by the low nucleophilicity of the indolic nitrogen. A dichlorophosphite intermediate is 
first formed from the SN2 reaction between the hydroxyl group and PCl3. The phosphorus 
center is susceptible to attack by nucleophile due to its relatively low electronegativity 
(i.e. Pauling scale value of 2.19 compared to carbon 2.55)
22 
and attachment to two 
electron withdrawing chloride groups. However, the lone pair on the indolic nitrogen is 
not readily available for donation because it is delocalized into the aromatic system.23 
(Figure 2) Hence, the subsequent formation of the cyclized phosphorochloridite 25 did 
not proceed rapidly and permit competing reaction by the amide group. In scheme (b), the 
rigidity of the cyclic system could have promoted the neighboring group participation. 
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The driving force may be a relief of strain from the tricyclic fused portion of the ring 
system. However, this path is less likely because trivalent phosphorus species is typically 


























































      (b) Rigidity of System
      O-Participation:
N-Participation:








Figure 3  Conjugation in Indolic System  
 
   The phosphorus intermediates resulted from these pathways would readily be 
hydrolyzed to yield pentavalent oxo or hydroxyl phosphorus species that typically give 
rise to 31P NMR signal at around 10 – -10 ppm. This may explained the experimentally 
observed major signals. 
 
2.3.3.3 Research on rigidity of the cyclic system 
In particular, such complication caused by neigbouring group participation could 
have been promoted by the rigidity of the cyclic system or the low nucleophilicity of the 
indolic nitrogen. As such, a preliminary study was conducted to investigate the influence 


































Scheme 15 (a) CBzCl, NaHCO3,H2O; (b) DIBAH, CH2Cl2, -78°C
(c) Isopropylamine, NaBH3CN, MeOH/36% HCl(9:1) pH 6;
(d) PCl3, Et3N, CH2Cl2; (e) T3'OH, Et3N, CH2Cl2.




 Compared to auxiliary 24, the structurally less rigid auxiliary 41 contains a more 
nucleophilic amino substituent as well as a carbamate moiety equally capable of 



















Figure 4 Neighboring Carbamate Participation  
 
   Auxiliary 41 was synthesized in three steps (overall yield of 37%). Stirring compound 
38 and benzyl chloroformate in aqueous carbonate solution25
 
for 23 hours afforded benzyl 
carbamate 39 quantitatively (i.e. 98% yield). The ester group in compound 39 was 
subsequently reduced by DIBAH
26 
to form aldehyde 40. In this step, the reduction was 
limit to a single oxidation stage through various controls. Firstly, the reaction temperature 
was maintained at -78 °C throughout the reduction process. Secondly, the addition of 
DIBAH was performed slowly with vigorous stirring. Lastly, the reaction was quenched 
immediately upon establishing the completion of the reaction by TLC. These controls are 
essential as elevated temperature, rapid addition of DIBAH and prolong stirring tend to 
promote further reduction of the aldehyde to alcohol. Initially, aldehyde 40 was isolated 
and then converted to compound 41. However, aldehyde 40 is not very stable and 
appeared to deteriorate after the work-up, complicating the next reaction and led to 
extremely low yield. Thus, the reductive amination was carried out in situ immediately 
after the DIBAH reaction was quenched, providing auxiliary 41 in a much improved 
yield of 38 % over the two steps.  
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The synthesis of cyclic phosphorochloridite 42 and phosphoramidite 43 proceeded 
smoothly according to the procedure established earlier for compound 37. Twenty 
minutes after the addition of auxiliary 41 to a CH2Cl2 solution of PCl3 in a NMR tube, 
31P 
NMR showed a major signal at 155.7 ppm corresponding to phosphorochloridite 42. This 
result is in marked contrast to that of phosphorochloridite 36 which was only observed 
after extensive heating. As such, the much slower rate of phosphorochloridite formation 
in the tryptophan derived auxiliary system substantiated the lower reactivity of the indolic 
amino group. Competing nucleophilic displacement by the amide moiety is thus likely. 
Some minor signals were observed at ~170 and ~140 ppm. As such, the reaction mixture 
was heated and monitored by 31P NMR for any changes. The major signal prevailed after 
overnight heating at 50 °C, so a solution of T3’OH in Et3N and CH2Cl2 was added at 0 °C. 
After 3 hours, 31P NMR revealed the presence of a predominant isomer at 134.0 ppm. 
TLC also displayed clearly one major product spot. Purification by a fast column 
chromatography afforded cyclic phosphoramidite 43 as a single diastereomer. It is 
possible to propose a structure for phosphoramidite 43 based on relevant analogous 
literature studies.27 From 13C NMR spectrum, the coupling constant between thymidine 
C-3’ and phosphorus (i.e. 
2
J = 19.2 Hz) is indicative of axially oriented OT
3
’ group. Thus, 
compound 43 would likely adopt the chair conformation with the sterically bulky 
carbamate group positioned in the equatorial position and an axial OT
3







Figure 5 Structure of Phosphoramidite 43  
   The result from model reaction demonstrated that the formation of cyclic 
phosphoramidite 43 using L-threonine derived auxiliary system is not complicated by any 
participation of the carbamate moiety. Although this result alone cannot prove that the 
amide participation is driven by the inherent nature of the tryptophan derived auxiliary 
system, it does support our propositions. Further studies are definitely necessary to 





2.4 Future work 
   From the results gathered so far, it seems inappropriate to install an amide moiety in 
the tryptophan derived auxiliary system before the formation of phosphoramidite as such 
installation complicates the formation of the tetracyclic phosphorus intermediates. 
There is one way to by pass the failure of the formation of phosphoramidite caused by 
the neighbouring group of amide: installation of the amide group at a later stage. From 
the result and discussion above, we knew that auxiliary 14 can form phosphoramidite 
with excellent diastereoselectivity when it was treated with T3’OH and T5’OH. 
Debenzylation and installation of amide group can be done after that stage. Reacting 
chiral auxiliary 35 with phosphorus trichloride, followed by 5’-O-TBS-thymidine (T3’OH) 
would yield cyclic phosphoramidite, which can be equilibrated to give a 
thermodynamically more stable isomer (Scheme16, c). Treatment of cyclic Phosphorami- 
dite with 3’-O-TBS-thymidine (T5’OH) in the presence of five equivalent of DBU would 
afford a phosphite trimester (Scheme16, d). Afer installation of amide group, 
Sulfurization with Beaucage’s reagent would provide a phosphothioate (Scheme 16, e, f). 
Amide participation would release the thymidine dime and yield a species of type a, 
which upon treatment with diethyamine would get chiral auxiliary 24. This can be used to 













































Scheme 16 (a) TBAF, THF; (b)PCl3, Et3N, CH2Cl2. TBAF=tetrabutylammonium fluoride
(c) T3'OH, Et3N, CH2Cl2 (d) T5'OH, DBU, THF (e) Pd/C, H2, MeOH (f) 2-Chloro-N,N-diethylacetamide,







































 Chirally pure phosphoramidite can be accessed easily from highly efficient novel 
auxiliary 41. The neighboring carbamate group present may be used for its removal. Thus, 
it also poses as an attractive candidate for further exploration. These studies should 
provide more insight in the design of more efficient and reusable auxiliaries.  
 
2.5 Conclusion 
 We compared the structure between auxiliary a and auxiliary 24 to find there are two 
differences. Ester group in position C-3 and amide group in N-2 in auxiliary might result 
in the failure of formation of cyclic phosphoramidite (Figure 1). We therefore 
synthesized auxiliary 35 (Figure 2) bearing ester group in C-3 to react with phosphorus 
trichloride and 5’-O-TBS-thymidine. Cyclic phosphoramidite was afforded. We proposed 
that neighbouring amide paticpation may impede the formation of the tetracyclic 
phosphorus intermediates. Possible mechanism of neighbouring amide participation was 
suggested. 
Structurally less rigid L-threonine derived auxiliary 41, which possessed a more 
nucleophilic amino group and a potential carbamate participant, successfully formed the 
corresponding cyclic phosphoramidite. This implied that the complication caused by the 
amide moiety in auxiliary 24 may be promoted by the inherent properties of the 
tryptophan derived auxiliary system i.e. low nucleophilicity of indolic nitrogen or rigidity 
of the system. There is no precedent literature concerning such study. Thus, further 
investigations are essential to ascertain the actual causes and verify the application of this 
novel concept.  
 
2.6 Experimental section 
General Materials and Methods 
Nuclear magnetic resonance spectra for 1H, 13C and 31P NMR were recorded on a 
Bruker ACF300 (300 MHz) spectrometer. Chemical shifts are reported in parts per 
million (ppm, δ) and referenced with respect to tetramethylsilane (0.00 ppm) or the 
residual signals of solvent: CDCl3 (
1H NMR: 7.26 ppm, singlet; 13C NMR: 77.5 ppm, 
triplet); CD3COCD3 (




NMR, 85% H3PO4 was used as an external reference (0.00 ppm). Monitoring of crude 
mixture in non-deuterated solvent using 31P NMR was performed without locking and 
shimming. The multiplicities in spectra assignment were recorded as: s (singlet), d 
(doublet), t (triplet), q (quartet), qn (quintet), m (multiplets), br (broad), dd (doublet of 
doublets) or ddd (doublet of doublet of doublets). Coupling constants (J) were recorded 
in Hertz (Hz) whilst the number of protons for a given resonance was indicated by nH. 
Abbreviations used in resonance assignment: Ar = aromatic; Ph = phenyl.  
   MS ESI spectra (positive and negative mode) were recorded on a Finnigan/MAT 
LCQ quadrupole ion trap mass spectrometer, coupled with the TSP4000 HPLC system 
and Crystal 310 CE system. MS was reported in units of mass over charge ratio (m/z).  
THF was distilled from sodium benzophenone ketyl, triethylamine and acetonitrile 
from CaH2. Anhydrous DMF was purchased fiom Aldrich in sure-seal bottles and used 
with no further drying. All chemicals were purchased from Aldrich Chemical Company 
Inc. and were used without futher purification. 
Thin-layer chromatography (TLC) was performed using Kieselgei 60 F, aluminum 
backed plates (0.2 mm thickness). Column chromatography was performed on 230-400 
mesh silica gel (Merck). 
All air sensitive experiments were performed under dry argon with freshly distilled 
anhydrous solvents and glassware previously dried overnight on an oven. 
  















To a solution of L-tryptophan methyl ester (1.1 g, 5 mmol) and benzaldehyde (0.55 ml, 
5.5 mmol) in methanol (40 ml) was added sodium cyanoborohydride (314 mg, 5 mmol). 
The pH of the solution was then adjusted to around 6 by adding acetic acid. The mixture 
was stirred at room temperature for 3 hours, and acetic acid was added during the 
reaction occasionally to maintain the pH of the solution at 6. Distilled water was added to 
the reaction mixture till the white cloudy precipitate formed, pH of the mixture was then 
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adjusted to around 8 by adding aqueous ammonia. The mixture was extracted with 
chloroform several times, the combined organic extracts was washed with brine, and 
dried over magnesium sulfate. Purification by flash chromatography afforded the desired 
product as a white solid (0.96 g, 63%).  
1H NMR(300 MHz, CDCl3) δ=3.24 (dd, 1H, J.8.6, 14.3 Hz, ArCH2), 3.55 (dd, 1H, J.4.9, 
14.4 Hz, ArCH2), 3.73 (s,3H, OCH3), 4.26 (dd, 1H, J.4.9, 8.6 Hz, CHN), 6.89 (d, 1H, 
J.2.1 Hz, ArH), 7.07±7.16 (m, 2H, ArH), 7.17±7.40(m, 4H, ArH), 7.63±7.66 (m, 2H, 
ArH), 7.85 (s, 1H, NvCH) and 8.17 (br, 1H, NH). 13C NMR (75 MHz, CDCl3) δ 175.7, 
139.9, 136.5, 128.6, 128.5, 127.8, 127.3, 123.2, 122.3, 119.7, 119.1, 111.5, 111.4, 61.5, 
52.4, 52.0, 29.6; MS (ESI) m/z 309 [M + H]
+




















A mixture of thymidine (1.0 g, 4 mmol), imidazole (1.1 g, 16 mmol) and TBSCl (1.3 g, 
8.4 mmol) in DMF (15 mL) was stirred at room temperature for 15 h, and then EtOH (10 
mL) was added. The resulting mixture was partitioned between AcOEt and H2O, and the 
organic layer was washed with aqueous saturated NaHCO3, H2O, and brine, dried, and 
evaporated. A solution of the residue in THF/H2O/acetic acid (1:1:3, 30 mL) was stirred 
at 0 °C for 2 h and then aqueous saturated Na2CO3 (600 mL) was added. The resulting 
mixture was extracted by AcOEt (5 times), and the extract was washed with brine, dried 
(Na2SO4), and evaporated. The residue was purified by column chromatography (silica 
gel; AcOEt/hexane =1:1) to afford the desired product as a white foam (0.85 g, 60%).  
1H NMR (CDCl3, 300 MHz) δ=8.43 (br s, 1 H,NH-3), 7.63 (d, 1 H, H-6, J =1.3 Hz), 6.13 
(dd, 1 H, J = 6.8, 6.8 Hz), 4.50 (m, 1 H, H-3’), 3.92 (dd, 1 H, H-5’a, J =2.5, 12.4 Hz), 
3.75 (dd, 1 H, H-5’b, J =3.5, 12.4 Hz), 2.35(m, 1 H, H-2’a), 2.21 (ddd, 1 H, H-2’b, 
J )=3.9, 6.8, 13.3Hz), 1.92 (s, 3 H, CH3-5), 0.90 [s, 9 H, Si-C(CH3)3], 0.09(s, 6 H, 
2Si-CH3). 13C NMR (75 MHz, CDCl3) δ 164.3, 150.8, 137.4, 111.3, 87.9, 87.1, 71.9, 62.3, 
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40.8, 26.0, 18.3, 12.8, -4.4, -4.5; MS (ESI) m/z 379 [M + Na]
+
, m/z 735 [2M + Na]
+
; m/z 
355 [M – H]
–















Imidazole (340 mg, 10 mmol) was added to a stirring solution of thymidine (0.48 g, 2 
mmol) in DMF (15 mL) at 0 °C and the resulting solution was stirred at this temperature 
for 30 minutes. TBDMS-Cl (0.33 g, 2.2 mmol) was then added at this temperature, and 
the solution allowed to stire at room temperature for a further 15 hours. Water (50 mL) 
and ether (50 mL) were then added and the separated aqueous phase was washed with 
ether (2×50 mL). The combined organic extracts were washed with water (150 mL), 
brine (100 mL) and dried (MgSO4). Removal of the solvent in vacuo and purification of 
the residue by column chromatography (SiO2, ether) provided the desired product as a 
white solid. (0.25g, 69 %) 
1H NMR (CDCl3, 300 MHz) δ=8.11 (1H, br s, NH), 7.50 (1H, s, H-6), 6.39 (1H, dd, J 8.3, 
5.6 Hz, H-1’), 4.43 (1H, m, H-3’), 4.07 (1H, m, H-4’), 3.88 (1H, dd, J 11.4, 2.5 Hz, H-5’), 
3.82 (1H, dd, J 11.4, 2.5 Hz, H-5’), 2.41 (1H, ddd, J 13.6, 5.6, 2.0 Hz, H-2’), 2.06 (1H, 
ddd, J 13.6, 8.4, 5.6 Hz, H-2’), 1.93 (3H, s, Me), 0.93 (9H, s, (CH3)3), 0.13 (3H, s, 
(CH3)2Si), 0.12 (3H, s, (CH3)2Si). 
 
(1S, 3S)-Methyl 1-((tert - butyl dimethyl silyloxy) methyl) -2, 3, 4, 9- 
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Nb-benzyl tryptophan methyl ester (101.64 mg, 0.33 mmol) and tert-butyldimethyl (silyl- 
oxy)acetaldehyde (63.5 μl, 1 mmol) were heated to reflux overnight. The reaction 
mixture was quenched with deionized water and extracted with dichlomethane (3×10 ml). 
The extracts were combined and washed with deionized water (10 ml), dried over 
anhydrous MgSO4 and concentrated under reduced pressure. The crude product was 
purified by column chromatography (Ethyl acetate/hexane= 1:30) to afford the desired 
product as a white solid (114 mg, 72%). 
1H NMR (CDCl3, 300 MHz) δ=8.40 (1H, s, NH),7.57 (1H, d, J=7.6), 7.19-7.44 (6H, m), 
7.13-7.16 (2H, m), 4.20-4.23 (1H, m), 4.00-4.55 (4H, m) 3.72 (3H, s), 3.60-3.66 (1H, m) 
3.15 (2H, dq), 0.95( 9H, s), 0.05 (6H,d J=5.72).13C NMR (75 MHz, CDCl3) δ 173.8, 
140.1, 136.5, 135.2, 128.7, 128.6, 127.4, 127.0, 121.8, 119.5, 118.4, 111.1, 106.5, 66.8, 
59.2, 57.7, 55.5, 52.1, 26.3, 23.0, 18.5, -5.1, -5.2; MS (ESI) m/z 465 [M + H]
+
, m/z 487 
[M + Na]
+




Cis-Diastereomer of 22: (1R, 3S)-Methyl 2-benzyl-1-((tert-butyldimethyl 
silyloxy) methyl)-2, 3, 4, 9-tetrahydro-1H-pyrido[3, 4-b] indole-3-carbo- 
xylate. 
 
1H NMR (300 MHz, CDCl3) δ 8.60 (br s, 1H, Indole NH), 7.52 (d, J = 8.1 Hz, 1H, ArH), 
7.42 (d, J = 7.2 Hz, 2H, ArH), 7.36–7.25 (m, 4H, ArH), 7.18–7.06 (m, 2H, ArH), 
4.15–3.89 (m, 5H), 3.74 (t, J = 9.8 Hz, 1H), 3.60 (s, 3H, OCH3), 3.30–3.23 (m, 1H, 
ArCH2), 3.09 – 3.02 (m, 1H, ArCH2), 0.92 (s, 9H, C(CH3)3), 0.02 (2 s, 6H, Si(CH3)2); 13C 
NMR (75 MHz, CDCl3) δ 174.5, 139.7, 136.2, 135.0, 128.8, 128.7, 127.6, 126.9, 121.8, 
119.4, 118.4, 111.1, 106.1, 65.8, 59.8, 58.7, 58.2, 52.1, 26.3, 22.5, 18.5, -5.1, -5.2; MS 
(ESI) m/z 465 [M + H]
+ 




(1S, 3S)-Methyl 1–(hydroxymethyl)-2, 3, 4, 9-tetra hydro-1H-pyrido[3, 
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Compound 22 (200 mg, 0.43 mmol) was suspended in EtOH (10 ml) and ethanolic HCl 
(5%, 5 ml) was added dropwise to form a clear solution. The solvent was removed under 
reduced pressure. The residue was then dissolved again in EtOH (10 ml) and the solvent 
was removed under reduced pressure. This process was repeated for three times after 
which Pd/C (10%, 100 mg) was added. The mixture that resulted was allowed to stir at rt 
under an atmosphere of hydrogen for 5 hours. The catalyst was removed by filtration, and 
the solid was washed with EtOH (3×10 ml). The solvent was removed under reduced 
pressure. The residue was dissolved in a mixture of CH2Cl2 and 15% aqueous NaHCO3 
(5:1, 20 ml). The aqueous layer was extracted with CH2Cl2 (2×10 ml), and dried over 
anhydrous Na2SO4. Removal of the solvent under pressure afforded the crude product, 
which was purified by chromatography on silica gel (EA:Hexane=1:1) to afford a slightly 
brown foam (70 mg, 63%). 
1H NMR (CDCl3, 300 MHz) δ=8.27 (br, s, 1H, Indole NH), 7.46-7.49 (m, 1H, ArH), 
6.99-7.26(m, 3H, ArH), 4.05-4.08 (t, J=6.6 Hz 1H), 3.88-3.92 (1H, m), 3.72 (3H ,s), 3.66 
(1H.d J=6.3), 3.50 (2H, br, s, NH), 3.09 (1H, dd), 2.90-2.93 (m, 1H); 13C NMR (75 MHz, 
CDCl3) δ 174.4, 136.4, 132.4, 126.9, 122.4, 119.9 118.4, 111.5, 108.0, 64.2, 52.9, 52.6, 
52.2, 25.5; MS (ESI) m/z 261 [M + H]
+





(1S, 3S)-Methyl 2-(2-(diethylamino) -2- oxoethyl)-1-(hydroxylmethyl) -2, 
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Compound 1(50 mg, 0.2 mmol) was added to a stirred solution of NaI (60 mg, 0.22 mmol) 
and K2CO3 (55.2 mg, 0.4 mmol) in HPLC acetone under Argon at room temperature. The 
reaction mixture was refluxed overnight. After evaporation of acetone, the residue was 
quenched in CH2Cl2 (10 ml) and was washed with deionized water (3×10 ml). The 
organic layer was dried over anhydrous MgSO4, Removal of the solvent under pressure 
afforded the crude product, which is purified which was purified by chromatography on 
silica gel (Ethyl acetate:Hexane=1:1) to afford the desired product as a yellow solid (53 
mg, 71%) 
1H NMR (CDCl3, 300 MHz) δ=8.52 (1H, br, s, NH), 7.48 (1H, d), 7.26-7.32 (1H, m), 
7.08-7.13 (2H, m), 4.12(2H, dt), 3.73-3.84 (3H, m), 3.72 (3H, s), 3.08-3.46 (7H, m), 1.12 
(6H, d); 13C NMR (75 MHz, CDCl3) δ 173.5, 170.4, 136.9, 131.4, 127.0, 122.1, 119.7, 
118.3, 111.5, 108.2, 63.4, 61.2, 58.1, 52.4, 52.0, 41.3, 41.0, 22.2, 14.5, 13.3; MS (ESI) 
m/z 396 [M + Na]
+




























Freshly distilled phosphorus trichloride (12.0 μl, 0.138 mmol) was added slowly to a dry 
two-necked round bottom flask containing a solution of compound 5 (0.0504 g, 0.135 
mmol), dichloromethane (10 ml) and triethylamine (50.0 μl, 0.358 mmol) at 0 °C. After 
stirring for 20 minutes, a solution of 5’-O-TBDMS-thymidine (52.4 mg, 0.147 mmol) and 
triethylamine (20.0 μl, 0.143 mmol) in dichloromethane (2.0 ml) was added to the 
reaction mixture at 0 °C. The reaction mixture was warmed up slowly to room 
temperature and refluxed overnight. 2. To a dichloromethane (5.0 ml) solution of 
phosphorus trichloride (12.5 μl, 0.143 mmol) in a scrupulously dried Schlenk flask at 0 
°C was added slowly a solution of compound 5 (0.0533 g, 0.143 mmol) in 
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dichloromethane (5.0 ml) containing triethylamine (50.0 μl, 0.359 mmol). The flask was 
then sealed with a glass stopper. After heating the reaction mixture at 50 °C for 24 hours, 
a solution of 5’-O-TBDMS-thymidine (0.0358 g, 0.100 mmol) and triethylamine (20.0 μl, 
0.143 mmol) in dichloromethane (5.0 ml) was added to the mixture at 0 °C. The flask 
was warmed up slowly to room temperature. 31P NMR (121.50 MHz, CDCl3 ) δ150–115, 
10– -5.  
 
(1S, 3S)-Methyl 2-benzyl-1-(hydroxymethyl)-2, 3, 4, 9-tetrahydro-1H-  

















Tetrabutylammonium fluoride (0.70 ml, 0.700 mmol) was added to a solution of 
compound 22 (0.1581 g, 0.340 mmol) in dry tetrahydrofuran (3.40 ml). After stirring for 
30 minutes under argon, the solvent was removed in vacuo. The resulting residue was 
dissolved in dichloromethane and washed with saturated NH4Cl (aq), followed by water 
and brine. The organic extract was dried over Na2SO4 and the solvent was removed in 
vacuo. The crude product was purified by flash column chromatography (Hexane/AcOEt 
3:1) to yield the desired product as a slight yellowish solid (0.1147 g, 96% yield).  
1H NMR (300 MHz, CD3COCD3) δ 9.85 (br, s, 1H, Indole NH), 7.54–7.50 (m, 3H, ArH), 
7.41–7.27 (m, 4H, ArH), 7.15–7.02 (m, 2H, ArH), 4.18–4.13 (m, 2H, NCHCO2 and 
ArCHN), 4.01–3.77 (m, 7H, OCH2, NCH2Ph and OCH3), 3.23–3.00 (m, 2H, ArCH2), 
2.91 (br, s, 1H, OH); 13C NMR (75 MHz, CD3COCD3) δ 173.3, 140.5, 137.4, 133.7, 
129.3, 128.8, 127.6, 121.6, 119.3, 118.2, 111.6, 107.1, 64.0, 58.5, 58.0, 54.4, 51.6, 22.1; 
MS (ESI) m/z 373 [M + Na]
+





































To a dichloromethane (0.25 ml) solution of phosphorus trichloride (8.8 μl, 0.101 mmol) 
in a scrupulously dried NMR tube at 0 °C was added slowly a solution of compound 35 
(0.0353 g, 0.101 mmol) in dry dichloromethane (1.00 ml) and triethylamine (30.0 μl, 
0.215 mmol). The NMR tube was then sealed. Initially 31P NMR indicated several 
resonances. After heating at 50 °C for 24 hours, a major resonance at 143.6 ppm was 
observed. A solution of 5’-O-TBDMS-thymidine (0.0358 g, 0.100 mmol) and 
triethylamine (14.0 μl, 0.100 mmol) in dichloromethane (0.60 ml) was added to the NMR 
tube at 0 °C. The NMR tube was re-sealed and warmed up slowly to room temperature. 
After 30 minutes, 31P NMR showed a major resonance at 118.0 ppm.  
 












Sodium bicarbonate (1.1733 g, 13.97 mmol) and benzyl chloroformate (1.00 ml, 6.749 
mmol) was added to a solution of L-threonine methyl ester hydrochloride 38 (1.0485 g, 
6.182 mmol) in water (60 ml). After stirring for 23 hours, the mixture was extracted with 
ether. The combined organic extract was washed with water, followed by brine and dried 
with Na2SO4. Removal of solvent in vacuo provided the desired product as a white solid 
(1.6177 g, 98% yield). 1H NMR (300 MHz, CDCl3) δ 7.38–7.32 (m, 5H, ArH), 5.53 (br, 
d, J = 8.3 Hz, 1H, OCONH), 5.14 (s, 2H, CH2Ph), 4.35 and 4.32 (2 br, s, 1H each, OCH, 
 62
OCONHCH), 3.78 (s, 3H, OCH3), 1.92 (br s, 1H, OH), 1.26 (d, J = 6.4 Hz, 3H, 
OCHCH3); 13C NMR (75 MHz, CDCl3) δ 172.0, 157.0, 136.5, 128.9, 128.5, 128.4, 68.3, 
67.6, 59.5, 52.9, 20.2; MS (ESI) m/z 290 [M + Na]
+
, m/z 557 [2M + Na]
+
; m/z 266 [M – 
H]
–


















To a stirred solution of methyl ester 39 (0.6379 g, 2.386 mmol) in dry dichloromethane 
(10.0 ml) at -78 °C was added diisobutylaluminum hydride (DIBAH, 1M in hexanes, 
8.60 ml, 8.60 mmol) at such a rate as to maintain the temperature at -78 °C (ca. 45 min). 
After the reaction had completed (after an additional 30–45 min as monitored by TLC), a 
solution of MeOH/36% HCl (aq) (9:1, 15.0 ml) was added slowly until no white fume 
was observed while keeping the temperature at -78 °C. The resulting cloudy crude 
mixture was cooled to 0 °C and isopropylamine (2.05 ml, 23.86 mmol) was added. The 
pH was adjusted to around 6 using MeOH/35% HCl (aq) and the reaction mixture was 
stirred under argon for 30 minutes at 0 °C. Subsequently, sodium cyanoborohydride 
(0.4499 g, 7.159 mmol) was added and the resulting mixture was stirred overnight at 
room temperature. The mixture was adjusted to pH 11 with 18M NaOH (aq) and 
dichloromethane was removed in vacuo. Water was added to the reaction mixture and the 
aqueous layer was extracted with diethyl ether. The organic extract was acidified with 
1M HCl (aq) and the resulting aqueous layer was washed with diethyl ether. Next, the 
aqueous layer was basidified to pH 11 using saturated NaHCO3 (aq) and 18M NaOH (aq) 
and extracted with diethyl ether. The final organic extract was washed with water, 
followed by brine and dried over Na2SO4. The solvent was removed in vacuo to yield a 
crude colourless viscous liquid. Purification by flash column chromatography 
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(Hexane/AcOEt/Et3N 10:8:1) afforded the desired product as colourless viscous liquid 
(0.2513 g, 38% yield).  
1H NMR (300 MHz, CDCl3) δ 7.37–7.31 (m, 5H, ArH), 5.43 (br d, J = 7.4 Hz, 1H, 
OCONH), 5.12 (s, 2H, CH2Ph), 4.13–4.09 (m, 1H, OCH), 3.59–3.56 (m, 1H), 3.23–3.19 
(m, 1H), 2.79–2.65 (m, 2H), 2.00 (br s, 2H, NH and OH), 1.15 (d, J = 6.4 Hz, 3H, 
OCHCH3), 1.05 (d, J = 6.3 Hz, 6H, NCHCH3); 13C NMR (75 MHz, CDCl3) δ 156.9, 
136.8, 128.9, 128.5, 128.4, 71.0, 67.2, 54.4, 50.9, 49.5, 23.3, 23.0, 20.2; MS (ESI) m/z 
281 [M + H]
+
, m/z 561 [2M + H]
+
























To a dichloromethane (0.25 ml) solution of phosphorus trichloride (16.8 μl, 0.193 mmol) 
in a scrupulously dried NMR tube at 0 °C was added slowly a solution of compound 41 
(0.0546 g, 0.195 mmol) in dry dichloromethane (0.50 ml) containing triethylamine (60.0 
μl, 0.430 mmol). The NMR tube was then sealed and heated at 50 °C. After 20 minutes, a 
major resonance at 155.7 ppm was observed and persisted after overnight heating. A 
solution of 5’-O-TBDMS-thymidine (0.0765 g, 0.215 mmol) and triethylamine (30.0 μl, 
0.215 mmol) in dichloromethane (0.4 ml) was added slowly to the NMR tube at 0 °C. 
The NMR tube was re-sealed and placed aside with occasional swirling until a major 
signal at 134.0 ppm was observed (ca. 3 hours). The solvent was removed in vacuo and 
purification of the residue by flash chromatography (Hexane:EtOAc:Et3N=5:2:2) 
afforded the desired product as a white foam of solid (0.0481 g, 37 % yield). The 
assignment of 1H NMR spectrum for this particular compound was based on 2D COSY 
experiment performed on AVANCE DRX500 (500 MHz) spectrometer. 
31P NMR (121.50 MHz, CDCl3) δ 134.50; 1H NMR (500 MHz, CDCl3) δ 7.49 (m, 1H, 
H-6), 7.37–7.30 (m, 5H, Ph), 6.36 (dd, J = 8.1, 5.6 Hz, 1H, H-1’), 5.46 (d, J = 9.9 Hz, 1H, 
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OCONH), 5.12 (s, 2H, OCH2Ph), 4.61–4.58 (m, 1H, H-3’), 4.53–4.51 (m, 1H, OCHCH3), 
4.03–4.02 (m, 1H, H-4’), 3.91–3.88 (m, 1H, H-5’), 3.80–3.73 (m, 2H, H-5’ and 
OCONHCH), 3.46 – 3.36 (m, 2H, PNCH2 and NCH(CH3)2), 2.83–2.78 (m, 1H, PNCH2), 
2.41–2.37 (m, 1H, H-2’), 2.13–2.08 (m, 1H, H-2’), 1.91 (d, J = 0.7 Hz, 3H, CH3-5), 1.16 
(d, J = 6.4 Hz, 3H, OCHCH3), 1.06 (d, J = 6.9 Hz, 3H, NCHCH3), 1.03 (d, J = 6.7 Hz, 
3H, NCHCH3), 0.92 (s, 9H, C(CH3)3), 0.11 (s, 6H, Si(CH3)2); 13C NMR (75 MHz, CDCl3) 
δ 164.1, 156.8, 150.7, 136.8, 135.5, 128.9, 128.5, 128.4, 111.3, 86.7 (d, J = 2.3 Hz), 85.1, 
74.0 (d, J = 19.2 Hz), 67.4 (d, J = 2.2 Hz), 67.2, 63.4, 49.9, 49.4 (d, J = 34.0 Hz), 42.4 (d, 
J = 4.4 Hz), 40.8 (d, J = 5.5 Hz), 26.3, 22.0 (d, J = 12.1 Hz), 21.2 (d, J = 3.8 Hz), 19.2 (d, 
J = 3.3 Hz), 18.7, 12.8, -5.0, -5.1; MS (ESI) m/z 665 [M + H]
+
, 687 [M + Na]
+
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 Chapter 3 Design of Proline Derivatives for Aldol Reactions 
 
3.1 Introduction 
3.1.1 Asymmetric Organocatalysis 
Traditionally, the catalytic asymmetric synthesis is almost equivalent to the uses of 
organometallic complexes in a chiral environment. The potential of small organic 
molecules in catalyzing the asymmetric organic reactions has attracted much attention 
only recently. Such organic catalysts have many advantages over their organometallic 
counterparts, such as easy manipulation, simple preparation and environmentally benign 
nature. 
Organocatalysis is the acceleration of chemical reactions with a substoichiometric 
amount of an organic compound which does not contain a metal atom. Despite the very 
recent introduction of this type of catalysis to synthetic chemistry, organocatalytic 
reactions look back on a venerable history. Evidence has been found that this type of 
catalysis played a determinant role in the formation of prebiotic key building blocks, such 
as sugars, and thus allowed the introduction and spread of homochirality in living 
organisms.1 According to this hypothesis, enantiomerically enriched amino acids, such as 
L-alanine and L-isovaline, which may be present with up to 15% ee in carbonaceous 
meteorites, catalyze the dimerization of glycal and an aldoltype reaction between glycal 
and formaldehyde to afford sugar derivatives with significant enantiomeric excess. 
Although organic molecules have also been used since the beginnings of chemistry as 
catalysts, their application in enantioselective catalysis has only emerged as a major 
concept in organic chemistry in the last few years.2, 3 As a result of both determined 
scientific interest, such as usually accompanies emerging fields, and the recognition of 
the huge potential of this new area, organocatalysis has received considerable attention.2, 
3 In 1971, a groundbreaking publication emerged from the literature from Eder, Sauer, 
and Wiechert demonstrating for the first time that asymmetry could be induced in a 
Robinson-type annulation using a meso-triketone by simply adding a catalytic amount of 
D- or L-proline Some mechanistic hypotheses were suggested in 1974 by Hajos and 
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Parrish, but it was not until a study by Agami and co-workers that strong evidence was 
obtained for the “enamine mechanism” .4, 5A notable recent extension of this work by List, 
Lerner, and Barbas has produced an intermolecular variant using proline as a catalyst 
which enantioselectively mediates aldol, Mannich, and conjugate addition reactions.6a 
During the past year a series of articles6b were published by MacMillan and 
co-workers on the topic of organocatalysis. These three papers demonstrated 
organocatalytic activation and enantioselection in several new reaction manifolds. The 
primary publication outlined the first organocatalytic Diels-Alder reaction using α, 
β-unsaturated aldehydes and chiral amines derived from amino acids.7 During the course 
of the Diels-Alder reaction, the chiral amine reversibly formed an iminium species with 
the aldehydic dienophile thus lowering the LUMO energy of this species. This is 
analogous to the Lewis acid-catalyzed Diels-Alder reaction where the Lewis acid 
coordinates the oxygen of the dienophile thus lowering its LUMO energy and 
accelerating the Diels-Alder reaction. 
Asymmetric organocatalysis represents a new and exciting field in organic chemistry. 
Organocatalysis is an attractive alternative to organometallic mediated asymmetric 
processes for environmental, monetary, and practical reasons. Although the breadth of 
possible reactions in the field is not as large as that of its organometallic counterpart, with 
critical mechanistic insight and novel catalyst development, new asymmetric 
organocatalytic reaction processes are bound to be close on the horizon. 
 
3.1.2 Proline 
Even if the first attempts to use pure organic molecules as chiral catalysts date back 
from the beginning of the twentieth-century, the first successful results were not obtained 
until the early 1970s by Hajos and Parrish,8
 
as well as Eder, Sauer and Wiechert9
 
independently. The two groups have discovered that asymmetry could be induced in a 
Robinson type annulation of an achiral triketone 1 by simply adding a catalytic amount of 

















Scheme 1: Hajos-Parrish-Eder-Sauer-Wiechert Reaction  
 
The first mechanistic hypotheses were suggested also by Hajos in 1974. Upon 
observation that no O-18 was incorporated into the product when the reaction was carried 
out in the presence of O-18 enriched water, Hajos and Parrish proposed that proline 
activates one of the two enantiotopic carbonyl acceptor groups by forming a carbinol 
amine 4 in the transition state (TS). Thirteen years later, Agami and co-workers published 
strong evidence (second order in proline, small negative nonlinear effect) for an enamine 
type intermediate and propose a TS 5 which involves two proline molecules.10
 
Recently, 
after taking a deeper look on the possible products of this reaction, Houk11
 
proposed a set 
of four TS’s, (two chair and two boat conformations), and with the help of density 
functional theory calculations they concluded that the chair TS’s are lower in energy than 
the boat TS’s. Of the two chair TS’s, the energy barrier of the one responsible for the 
formation of the (S, S) bicyclic ketol is lower than the barrier for the formation of the (R, 
R) product, a result which is in agreement with the experimental data. Swaminathan 
invoked a heterogeneous aldolization process which takes place on the surface of 





































Scheme 2: Selected TS Models for the Proline-Catalyzed Aldol Reaction
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 Recently, List, Lerner and Barbas have developed the first intermolecular version of a 
cross-aldol reaction between aldehydes as acceptors and ketones as donors using catalytic 
amounts of proline.13
 
While aromatic aldehydes gave products with moderate selectivity 
(~70% ee),14a
 
a large variety of α-mono- and α-disubstituted aliphatic aldehydes provided 
aldols with excellent enantioselectivities (up to 99% ee, Scheme 3).14b
 
Under optimized 
conditions, it can also be applied to α-unbranched aliphatic aldehydes to give products 
with up to 99% ee. Previously, the use of α-unbranched aldehydes in the 
cross-aldolization process was hindered by their self-condensation, fact which can be 
avoided now by carrying out the reactions under optimal conditions. List’s kinetic and 
theoretical studies on intra- and intermolecular versions of the reaction contradict Hajos 
and Agami’s findings and point to a unified enamine catalysis mechanism.15
 
List’s 
observations are consistent with Houk’s theoretical calculations, and the proposed 
metal-free Zimmerman-Traxler-type transition state 1116
 
invokes one single proline 
molecule which catalyses the reaction in the same manner as type I-aldolases and 





















R=p-NO2C6H5: 68% yield, 76% ee; R=t-Bi: 81% ,>99% ee
Scheme 3: Proline Mediated Intermolecular Aldol Reaction  
 
MacMillan further enlarged the substrate scope by demonstrating that α-unbranched 
aldehydes can be used as donors in the reaction with aldehyde acceptors to give products 
in high yields with up to 24:1 dr and >99% ee.18
 
Cordova reported the proline catalyzed 
direct asymmetric cross-aldol reaction of aldehydes in an ionic liquid medium, leading to 
optically pure 3-hydroxy aldehydes (99->99% ee) in high yields (68-78%) and good 
diastereoselectivities (3:1 to >19:1 dr).19
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An asymmetric intramolecular version of the Hajos-Parrish-Eder-Sauer-Wiechert 
reaction has also been developed, and the enolexo aldolization was successfully applied 
to various pentane-1, 5-dialdehydes to give products in high yields and 
diastereoselectivities, with up to 99% ee.20
 
Fascinated by these results, the scientific community became increasingly attracted to 
these small molecules and the potential behind them. Soon after, it was found that proline 
is capable of performing other types of reaction in a highly selective manner. For 
example, the proline catalyzed Mannich reaction offers practical access to a large number 
of enantiomerically enriched β-amino carbonyl compounds.21
 
Under optimized conditions, 
it can be carried out either directly, as a three-component one-pot reaction, or indirectly, 
using preformed imines and enolates. Various structurally diverse ketones and aldehydes 
have been tested in the reaction with different aniline derivatives to give products in high 
yields and excellent selectivities. The reaction is supposed to follow an enamine 
mechanism22
 
and occurs with diastereo- and enantioselectivity opposite to that of related 
































Scheme 4: Proposed TS for Proline Catalyzed Aldol and Mannich Reactions  
 
Surprisingly, only modest levels of enantioselection were achieved when L-proline was 
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In contrast, excellent yields and selectivities were achieved 
when L-α-methyl proline (10 mol%) was employed in the intramolecular alkylation 
reaction.28
 
No detectable racemization, self condensation or catalyst alkylation occurs 
during this process which provides access to enantiomerically enriched cyclopropane, 
cyclopentane and pyrrolidine derivatives. Also worthy of note is the α-amination of 
ketones and aldehydes which furnishes useful precursors for the synthesis of 
2-oxazolidinones and other natural and unnatural α-amino acids derivatives (Scheme 5).26
 
A similar enamine mechanism is suggested to rationalize the stereochemical outcome of 








10 mol%  L-Proline









1.5 eq.14 1.0 eq. 15 16
R=Me, i -Pr, n -Pr, n -Bu, Bn: 93-99% yield, 95-97% ee
Scheme 5: Proline Catalyzed Asymmetric  -Amination of Aldehydes  
Recently, MacMillan, Hayashi, Zhong, and soon after Cordova, independently 
















88% yield, 97% ee
Scheme 6: Proline Catalyzed Asymmetric  -Oxylamination of Aldehydes.  
 
MacMillan found that the use of chloroform as solvent and the superior reactivity of 
nitrosobenzene are suppressing the self-aldolization and α-amination pathways.25a 
Lowering the temperature to 4 °C also had a positive effect on the reaction selectivity and 
various aldehydes were enantioselectively oxidized in good yields under these mild 
conditions. In addition, lowering the catalyst loading from 10 to 0.5 mol% had no 
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significant detrimental influence on the enantioselectivity. Accordingly, the oxyamination 
of propanal in chloroform at 4 °C in the presence of 2 mol% L-proline afforded the 
α-aminooxy aldehyde in 88% yield and 97% ee. Zhong reported the in situ reduction of 
the carbonyl group of 19 to give the 1, 2-protected diol (secondary alcohol protected as 
an O-amino group) with high enantioselectivity.25b, 25c
 
Subsequent hydrogenation over 
Adams catalyst furnished the corresponding 1, 2-diol without any loss in the optical 
purity. Accordingly, various aliphatic aldehydes were converted into the corresponding 1, 
2-protected diols with excellent selectivities (94-99% ee). Hayashi reported that the same 
reaction can be performed in acetonitrile at −20 °C to give the protected diol in 


















20 18 21 22 23
CHCl3                  91% yield, > 99% ee                   -                                 -
DMSO                 70% yield, > 99% ee            22% yield, > 99% ee        -
DMSO                 70% yield, > 99% ee                   -                                  -
Scheme 7: Proline Catalyzed Asymmetric  - Oxyamination of Cyclic Ketones.  
 
Excellent chemo-, regio-, and enantioselectivities were reported by Cordova in the 
α-oxyamination of cyclic, as well as acyclic ketones (Scheme 7).25e, 26
The double oxyamination of the ketones with two available enol forms could be 
circumvented by slow addition of the nitrozo electrophile, via syringe pump, to the 
reaction mixture. The oxyamination of the acyclic ketones afforded, along with the 
O-addition adducts (>99% ee), small amounts of the aminated ketones with the same 
regioselectivity as the major products. At the same time, Hayashi applied the same 
methodology to different cyclohexanone derivatives to give products in good yields and 








3.1.3 Mechanism of proline-catalyzed aldol reaction 
 
In the early 1970s, Hajos and Parrish proposed two mechanisms of proline catalyzed 
aldol reaction. One of them involves the formation of a carbinolamine intermediate, 
followed by the displacement of the proline moiety by nucleophilic attack of the enol 
from the side chain ketone (Scheme 8, A).31 The other involves an enaminium 
intermediate acting as a nucleophile in the C-C bond formation with concomitant 
N-H---O hydrogen transfer (Scheme 8, C). 
   Although Hajos expressed a preference for the nucleophilic substitution mechanism 
(A), experimental evidence presented by Spencer,32 Wakselman33 and Eschenmoser34 
supported the involvement of enamine intermediates in amine- and amino-acid-catalyzed 
aldolizations. The general enamine mechanism is depicted in Scheme 3. Proline provides 
the acid catalysis for many of the steps, including the C-C bond formation shown in 
Scheme 8 B). Agamiet al.35-37 proposed a modified version of the enaminium mechanism 
involving a second proline molecule assisting in the N-H-O hydrogen transfer (Scheme 8, 
D). However, recent experimental studies by List’s group and theory by ours support a 
one-proline mechanism; nonlinear effects are actually not present in proline-catalyzed 
intramolecular aldolizations.38
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Scheme 8 Mechanisms proposed for the proline-catalyzed intromolecular aldol reactions  
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Currently, it is generally assumed that this novel asymmetric aldol reaction occurs 
via an enamine mechanism (Scheme 9). Proline, perhaps, functions as a 
“micro-aldolase” that provides both the nucleophilic amino group and an acid/base 
cocatalyst in the form of the carboxylate. This cocatalyst may facilitate each individual 
step of the mechanism, including the nucleophilic attack of the amino group, the 
dehydration of the carbinol amine intermediate (a), the deprotonation of the iminium 
species (b), the carbon-carbon bond forming step (c), and both steps of the hydrolysis of 
the iminium-aldol intermediate (d and e). The enantioselectivity can be explained with a 






















































3.2. Aim of the project 
 
L-proline has been, and still is one of the leading organocatalysts. The reason for its 
wide spread use and successful performance in many reactions has been attributed to its 
secondary amine functionality which results in a higher pKa value compared to the other 
natural amino acids often tested as catalyst. In addition it also has higher nucleophilicity 
and readily forms enamines or iminium ions with carbonyl functionalities and Michael 
acceptors. 
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The higher nucleophilicity can cause problems. Many partial steps in amine catalyzed 
reactions40 are equilibrium reactions and a catalyst of higher nucleophilicity can react in a 
number of ways in equilibrated reactions with present electrophiles. This possible 
problem is usually circumvented by a high catalyst loading. Commonly, proline is used at 
levels of around 20 mol%. 
There are other drawbacks in the use of proline such as its limit solvent compatibility 
and performance of reactions in very polar solvent. Therefore, more powerful proline 
surrogates and derivatives are strongly desirable. 
The initial aim in our organocatalyst program was to design organocatalysts (Figure 1) 
with the intention of overcoming some of these problems; we hoped to design catalysts 
which could be used in solvents more commonly used in organic synthesis with highly 
lipophilic substrates. In this project, we implemented two principal approaches to 
creating a new type of catalysis and high catalytic efficiency: one was the replacing of the 
carboxylic acid in proline with a urea or a thiourea unit would give the greater solubility 
that was desired. This would allow a greater range of solvents to be used with the 





















                             Figure 1  
The other was the creation of rather complicated but more cooperatively arranged 
hydrogen-bond networks that would be expected to stabilize a transition state, thereby 
promoting new reactivity and selectivity. To make such a hydrogen-bond network, a 
catalyst should provide, at the least, an additional binding site for a proton. In general, 
protonated ROH groups (H+---OH(R)) have a pKa value that is much smaller than that of 
protonated NH groups ((HN---H+) X-),41 which suggests that a nitrogen lone pair has a 
considerably stronger affinity for protons. An NH-type unit preserves a lone pair on the 
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nitrogen that can further accept a proton and, in this respect, is more suitable for catalysis 
than OH-type acids. 
In our project, the newly synthesized organocatalysts will be able to form two 
hydrogen bonds upon mixing with the aldehyde in aldol reaction.（Figure 2）In theory, it 
should be more favourable in activating the aldehyde as compared to proline which can 
only form one hydrogen bond, thus showing a higher yield, less reaction time and higher 
























Figure 2  
In this model, proline-derivatives first react with acetone, and then form an active 
intermediate enamine species. This uses two hydrogen bondings to position the incoming 
aldehyde, so that it not only forms the desired carbon-carbon bond, but invests it with the 
desired enantiomeric configuration which is more stable than the enantiomeric 
configuration formed by using proline as a catalyst. (Scheme 10) 
 
   Our own group took these ideas together and settled for using thioureas because they 
are a) more soluble in a variety of solvents; b) easier to prepare (thiophosgene is much 
easier to handle than phosgene; c) the thiocarbonyl group is a much weaker 
hydrogen-bond acceptor. As expected, the introduction of electron-withdrawing groups in 
the meta-position that are not capable of much hydrogen bondings themselves increases 
the catalytic efficiency. This observation is also in line with the fact that co-crystals are of 







































































Scheme 10 proposed mechanism of the proline derivative-catalyzed aldol reaction  
 
3.3. Results and Discussions 
3.3.1 The Synthesis of the Organocatalyst 24a 
Organocatalyst 24a (X=O) was synthesized as illustrated in scheme 11. L-proline 1 
was first converted into its methyl ester 2. After direct reductive amination, ester 2 was 
converted into N
b
-benzyl L-proline methyl ester 3. Reaction of N
b
-benzyl L-proline 
methyl ester 3 with ammonium gas at room temperature in methanol provided Nb-benzyl 
–prolinamide 4. Reduction of Nb-benzyl–prolinamide 4 by borane in THF afforded 
(s)1-benzyl 2-amino methyl pyrrolidine 5. Reaction of compound 5 with 3, 5-bis 
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(trifluoromethyl) phenyl isocyanate afforded compound 6, which was converted into 














































Scheme 11  Synthesis of organocatalyst 24a  
 
3.3.2 The Synthesis of the Organocatalyst 24b 
The synthesis of thiourea 24b was attempted as shown in Scheme 12. However, 
compound a instead of 24b was obtained after debenzylation of 6b. The reasons of it are 
still unclear. One of the possible reasons is that thiourea was poisoned by palladium 
























































































































In order to obtain the thiourea 24b, we used Boc to protect L-prolinol 2 so that we can 
avoid the procedure of debenzylation of 6b, which lead to the formation of compound a. 
As shown in Scheme 14, L-proline was first converted into L-prolinol 2. After protection 
of secondary amine with (Boc)2O, compound 2 was converted into Nb-Boc-L-prolinol 3. 
Reaction of Nb-Boc-L-prolinol 3 with mesyl chloride at 0 °C in dry THF provided 
mesylate 4, which was reacted with sodium azide to afford azide 5. Reduction of azide 5 
by triphenyl phosphane in THF afforded (S)-1-Boc-2-amino methyl pyrrolidine 6. 
Reaction of compound 6 with 3, 5-Bistrifluoromethyl phenyl isothiocyanate afforded 
thiourea 7, which was converted into organocatalyst 24b after deprotection by 




















































Scheme 14  Synthesis of organocatalyst 24b  
 
3.3.3 The Synthesis of the Organocatalyst 25a 
The synthesis of organocatalyst 25a is summarized in Scheme 15. The coupling 
reaction of Boc-L-Isoleucine and isopropylamine provided 6, which was converted into 7 
after deprotection. Compound 7 was converted into isocyanate 8 by reacting with 
triphosgene. Reaction of isocyanate 8 and amine 5 then afforded urea 9. After 




































































3.3. 4 Aldol reaction catalyzed by proline derivatives   
 
In our initial experiments, we studied the aldol reaction of acetone with 
4-nitrobenzaldehyde, wherein the acetone was a component of the solvent system 
anhydrous DMSO/acetone (4:1). The large excess of acetone was to enforce an 
equilibrium favoring the aldol addition product. Since acetone is also an inexpensive and 
commonly used solvent, use of a large excess can be justified. Organocatalysts 24a, 24 b, 
25a, 25b were studied (entry 1, 2, 3, 4, Table 1). We found that, after stirring the 
homogeneous mixture for 12 h at room temperature, no reactions catalyzed by 





 entry        catalyst      temp( °C)   time (h)      yield(%)  ee( %)
1 24a 25 12
2 24b 25 12




Direct Aldol Reaction of 4-Nitrobenzaldehyde with Acetone Catalyzed 
by Organic Molecules 24a, 24b, 25a
Table 1  
 
The failure of the reaction could due to the failure of enamine intermediate formation. 
Experiments have shown that the carboxylic acid group and pyrrolidine ring of proline 
are essential for enamine formation.44 Carboxylic acid group provide carboxylic acid 
proton not only for hydrogen bonding formation but also for the enamine formation (a, b) 

























































3.4 Future work 
   Barbas has screened a series of acids and found that the combination of 
pyrrolidine/acetic acid was superior to proline in reactivity when used in aldol reaction.47 
(Scheme 17). It seems that the combination of our proline derivatives/ acetic acid would 
get higher yield and higher ee value. Unfortunately, this project was discontinued due to 























Scheme 17 Proposed mechanism of pyrrolidine-acetic acid 








   In this project, we have synthesized proline derivatives 24 and 25 as organocatalysts 
for aldol reaction. Through the test of proline derivatives 24 and 25 catalyzed aldol 
reaction, we explored the concept of utilization of double hydrogen bondings upon 
mixing with the aldehyde in aldol reaction. Our preliminary studies suggested that acid 
component, in combination with our organocatalyst may promote the enamine formation 
and therefore catalyze efficient aldol reactions. 
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3.6 Experimental Section 
 
Organocatalyst 24a was synthesized according to scheme 11 
 





oxalyl chloride HN O
Omethanol
1 2  
 
 
To a solution of L-proline (2.3 g, 20 mmol) in methanol was added oxalyl chloride (2 ml, 
24 mmol) dropwise at 0 °C. After stirring at room temperature for 30 minutes, the 
resulting mixture was heated to reflux overnight. Methanol was evaporated, and the 
reaction mixture was diluted with ethyl acetate (30 ml) and was washed with saturated 
sodium bicarbonate (3×30 ml). The organic layer was dried over anhydrous MgSO4, 
filtered and concentrated to dryness under reduced pressure to afford the desired product 
as white liquid (2.38 g, crude yield 92%). 
 









2 3  
To a solution of L-proline methyl ester (645 mg, 5 mmol) and benzaldehyde (0.55 ml, 5.5 
mmol) in methanol (40 ml) was added sodium cyanoborohydride (314 mg, 5 mmol). The 
pH of the solution was then adjusted to around 6 by adding acetic acid. The mixture was 
stirred at room temperature for 3 hours, and acetic acid was added during the reaction 
occasionally to maintain the pH of the solution at 6. Distilled water was added to the 
reaction mixture till the white cloudy precipitate formed, pH of the mixture was then 
adjusted to around 8 by adding aqueous ammonia. The mixture was extracted with 
chloroform several times, the combined organic extracts was washed with brine, and 
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dried over magnesium sulfate purification by flash chromatography afforded the desired 
compound as colorless liquid (805 mg, 74%). 
1H NMR (75 MHz, CDCl3), δ=1.78-2.11 (m, 4H), 2.38-2.40 (m, 1H), 3.02-3.05 (m, 1H), 
3.22-3.27 (m, 1H), 3.55-3.59 (d, 1H), 3.64 (s, 1H), 3.86-3.90 (d, 1H), 7.21-7.56 (m, 5H). 
13C NMR (75 MHz, CDCl3), δ=22.9, 29.2, 51.6, 53.1, 58.6, 65.2, 127.0, 128.1, 129.1, 











3 4  
 
A solution of Nb-benzylproline methyl ester (1.5 g, 6.85 mmol) in methanol (20 ml) was 
filled with ammonium gas at room temperature for half an hour. The mixture was stirred 
at room temperature for three days. The solvent was then evaporated and the residue was 
purified by column chromatography (EA:Hexane=1:1) to get the desired product as a 
slightly yellow solid (1.02 g, 72%). 
1H NMR (300 MHz, CDCl3), δ=1.65-1.73 (m, 3H), 1.86-2.27 (m, 2H), 2.92-2.93 (m, 1H), 
3.08-3.13 (m, 1H), 3.35-3.39 (d, 1H), 3.87-3.91(d, 1H), 7.08-7.25 (m.5H). 13C NMR (75 
MHz, CDCl3), δ=23.9, 30.4, 53.6, 59.6, 67.3, 127.1, 128.3, 128.6, 138.5, 178.5. MS (ESI): 
m/e calculated for C12H16N2O [MH+]: 205.1, found 205.1. 
 








4 5  
 
The dried Nb-benzylprolinamide 4 (408 mg, 2 mmol) was slurried in THF (18 ml) and 
cooled to 15 °C. To this solution was added NaBH4 (530 mg, 14 mmol), followed by 
slow addition of BF3 ether. The addition of BF3 ether caused vigorous evolution of gas. 
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The slurry was further reflux overnight. MeOH (12 ml) was slowly added to quench 
excess borane, followed by slow addition of 10 ml of 2 N HCl. After aging for 30 min to 
ensure homogeneity, the reaction mixture was basified by 20 ml sodium hydroxide(5%), 
extracted with DCM (3×10 ml). The organic layer was combined and dried under reduced 
pressure to obtain compound 5 as colorless oil (298.7 mg, 78%). 
1H NMR (300 MHz, CDCl3), δ=1.58-1.66 (m, 2H), 1.83-1.84 (m, 1H), 2.12-2.17 (m, 2H), 
2.49-2.52 (m, 2H), 2.66-2.69 (m, 2H), 2.86-2.89 (m, 1H), 3.21-3.25 (d, 1H), 3.88-3.92 (d, 
1H), 7.21-7.56 (m, 5H). 13C NMR (75 MHz, CDCl3), δ=22.9, 27.9, 43.7, 54.37, 58.9, 
























(s)1-Benzyl 2-amino methyl pyrrolidine 5( 200 mg, 1.1 mmol) in anhydrous DCM was 
added 3, 5-Bis(trifluoromethyl) phenyl isocyanate (176 μL, 1 mmol) in 10 ml anhydrous 
DCM dropwise and stirred at room temperature overnight. The solvent was evaporated 
and purified by column chromatography (EA: Hexane=1:1) to afford a white foam (320 
mg, 72%). 
1H NMR(300 MHz, CDCl3), δ=1.60-1.68 (m, 4H), 2.74-2.87 (m, 2H), 3.16-3.20 (m, 2H), 
3.30-3.34 (m, 2H), 3.86-3.90 (m, 2H), 7.17-7.26 (m, 6H), 7.32-7.33 (m, 1H), 7.58-7.59 


























Urea 6 (160 mg, 0.36 mmol) was suspended in MeOH (10 ml) and methanolic HCl (5%, 
10 ml) was added dropwise to form a clear solution. The solvent was removed under 
reduced pressure. The residue was then dissolved in MeOH (5 ml) and the solvent was 
removed under reduced pressure. This process was repeated for three times after which 
Pd/C (10%, 60 mg) was added. The mixture that resulted was allowed to stir at room 
temperature under an atmosphere of hydrogen for overnight. The catalyst was removed 
by filtration. And the residue was washed with Methanol (3×10 ml). The solvent was 
removed under reduced pressure. The residue was dissolved in a mixture of DCM and 
15% aqueous NaHCO3 (20 ml). The aqueous layer was extracted with DCM (2×10 ml) 
and dried over anhydrous sodium sulfate. Removal of the solvent under pressure afforded 
a white solid (97 mg, 76%). 
1H NMR(300 MHz, CDCl3), δ=1.60-1.68 (m, 4H), 2.74-2.87 (m, 2H), 3.16-3.20 (m, 2H), 
3.30-3.34 (m, 2H), 3.86-3.90 (m, 2H), 7.67-7.68 (m, 1H), 7.80-7.81 (m, 2H); 13C 
NMR(75 MHz, CDCl3), δ=23.7, 27.3, 41.2, 45.2, 61.3, 115.2, 118.0, 121.3, 124.9, 131.5, 
141.0, 157.0. MS (ESI): m/e calculated for 24a [MH+]: 356.2 found 356.2 












L-prolinol (460 mg, 4 mmol) was added to a stirred solution of lithium aluminium 
hydride (305 mg, 8 mmol) in dry THF (20 mL) at 0 °C. The solution was allowed to 
gradually warm to ambient temperature and refluxed overnight. The reaction mixture was 
again cooled to 0 °C and 5 mL of Ethyl acetate was added. The reaction mixture was 
washed with 4 mL of 2.5 mol/L NaOH and was filtered through Celite and the filter cake 
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extracted with CH2Cl2 (3×10 mL). The filtrate was evaporated to leave pure compound 2 
(373.2 mg, 92%) as a colorless oil. 
1H NMR(300 MHz, CDCl3), δ=1.04-1.62(m, 4H), 2.69-2.71(m, 2H), 2.97-2.99(m, 1H), 













L-prolinol(540 mg, 5.34 mmol) was dissolved in a mixture of dioxane , water and 2 M 
aqueous NaOH (10.4 ml, 8.6 ml, 2.6 ml respectively) The solution was cooled in an 
ice/water bath for 15 minutes, followed by addition of Boc2O(1.28 g, 5.87 mmol). After 
the reagent was dissolved, the ice bar was removed and the reaction was allowed to 
proceed at ambient temperature until the starting material was consumed (1 h). The 
organic solvent was removed under reduced pressure and ethyl acetate (20 ml) was added 
to the crude compound in water. The pH was then adjusted to 7 and the title compound 
was extracted. The organic phase was washed with water (1×20 ml), dried with MgSO4 
and concentrated under reduced pressure, yielding of compound 3 (944.6 mg, 88%) as a 
colorless oil, which solidified in vacuo overnight. 
1H NMR (300 MHz, CDCl3), δ =1.40 (s, 9H), 1.71-1.92 (m, 4H), 3.24-3.37 (m, 4H), 
4.21-4.25 (m, 2H); 13C NMR (75 MHz, CDCl3), δ=23.8, 28.3, 47.3, 59.5, 66.9, 80.4, 
156.9. MS (ESI): m/e calculated for C10H19NO3 [MH+]: 200, found 200. 












Triethylamine (0.43 ml) was added to a solution of Boc-prolinol (201.26 mg, 1 mmol) in 
dry THF (10 ml), and the reaction flask was cooled in an ice/water bath for 15 min mesyl 
chloride (156 μl, 2.02 mmol) was added in a single portion, resulting in instantaneous 
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formation of a white precipitate. After 1 h, the mixture was diluted with dichloromethane 
(10 ml), washed with saturated aqueous NaHCO3 (10 ml), dried over MgSO4 and 
concentrated under reduced pressure. The intermediate mesylate 4 was obtained as 
colorless oil (253.7 mg, 91%).  
1H NMR (300 MHz, CDCl3), δ=1.30(s, 9H), 1.67-1.85(m, 4H), 2.85(s, 3H), 3.00-3.01(m, 
1H), 3.19-3.21(m, 2H) 3.84-4.10(m, 2H); 13C NMR (75 MHz, CDCl3), δ=23.8, 28.3, 47.3, 
59.5, 66.9, 80.4, 156.9. MS (ESI): m/e calculated for C11H21NO5S [MH+]: 302, found 302 
 














The mesylate 4 (253.7 mg, 0.91 mmol) was dissolved in dry DMF( 15 ml), and sodium 
azide (390 mg, 7 mmol) was added. The reaction mixture was stirred and kept at 64 °C 
for 16 h, and then diluted with ethyl acetate (25 ml) washed with water（3×10 ml）and 
saturated NaCl (10 ml), dried with MgSO4 and concentrated under reduced pressure. 
Crude azide was purified silica column chromatography (Ethylacetate:Hexane=1:8). 
Fractions containing the product were pooled and concentrated under reduced pressure, 
yielding azide 5 (173.8 mg, 84%) as colorless oil.  
 










Azide 5 (380 mg, 0.22 mmol) in anhydrous THF was reduced with triphenyl phosphane 
(116 mg, 0.44 mmol) and water (8.3 μl, 0.464 mmol).The reaction mixture was heated to 
reflux overnight. Diethyl ether (10 ml) was added to the remaining oil, and the pH of the 
aqueous phase was lowered to 1.75 with 2 M HCl with vigorous stirring. The aqueous 
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layer was separated and washed with diethyl ether (2×10 ml) and the pH was then 
adjusted to 13 with 2 M NaOH. After extraction with DCM (2×10 ml), the combined 
organic phases were dried over MgSO4 and concentrated under reduced pressure. 
(S)-1-Boc-2-amino methyl pyrrolidine 6 was obtained as colorless oil (377 mg, 89%).  
1H NMR(300 MHz, CDCl3), δ=1.34(s, 9H), 1.55-1.74 (m, 4H), 2.51-2.69(m, 2H), 
3.17-3.22 (m, 2H), 3.64-3.65(m, 1H). 13C NMR (75 MHz, CDCl3), δ=23.8, 28.3, 47.3, 
59.5, 66.9, 80.4, 156.9.MS (ESI): m/e calculated for C10H20N2O2 [MH+]: 200, found 200 
 
(S)-Tert-butyl 2-((3-(3, 5-bis(trifluoromethyl)phenyl)thioureido)methyl) 



















(S)-1-Boc-2-amino methyl pyrrolidine 6 (100 mg, 0.5 mmol) in anhydrous 
dichloromethane(10 ml) was added 3, 5-Bistrifluoromethyl phenyl isothiocyanate 
dropwise and stirred at room temperature overnight. The solvent was evaporated and the 
resulting reaction mixture was purified by column chromatography (EA:Hexane=1:4) to 























The white crystalline solid 7 (200 mg, 0.89 mmol) was dissolved in anhydrous 
dichloromethane (10 ml), followed by the addition of trifluoroacetic acid (0.68 ml, 8.9 
mmol) in one portion at 0 oC. After 1 h of stirring at room temperature, excess 
trifluoroacetic acid was removed at reduced pressure and the TFA salt was washed with 
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dichloromethane (10mlx3), neutralised with 2N NaOH (20 ml) and then extracted 
dichloromethane (10mlx4). The combined organic extracts were dried over anhydrous 
magnesium sulfate, filtered and concentrated in vacuo to give the desired compound as a 
white solid (98 mg, 54 %).   
1H NMR (300Hz, CDCl3), δ=1.60-1.68 (m, 4H), 2.74-2.87 (m, 2H), 3.16-3.20 (m, 2H), 
3.30-3.34 (m, 2H), 3.86-3.90 (m, 2H), 7.67-7.68 (m, 1H), 7.80-7.81 (m, 2H). 13C NMR 
(75 MHz, CDCl3), δ=24.0, 27.8, 44.8, 45.3, 61.5, 123.2, 124.8, 131.3, 131.8, 140.4, 182.9. 
MS (ESI): m/e calculated for 24b [MH+]: 372, found 372 
 
Organocatalyst 24 b was synthesized according to scheme 14 
 
Tert-butyl (1S, 2S)-1-(isopropylcarbamoyl)-2-methylbutylcarbamate 6.  
 














A 50 mL flask was charged with Boc-L-Isoleucine (462.6 mg, 2 mmol), DCC (454 mg, 
2.2 mmol) and HOBt (297.3 mg, 2.2 mmol). Anhydrous dichloromethane was then added 
followed by isopropylamine (187.4 μL, 2.2 mmol) in one portion at 0 oC. The reaction 
was allowed to stir at room temperature for 6 hours after which reaction mixture was 
filtered, extracted with dichloromethane, washed with 1N HCl, dried over anhydrous 
magnesium sulfate, filtered and concentrated in vacuo. The crude product was purified by 
column chromatography (Ethylacetate:Hexane=2:1) to afford the desired compound 6 a 
white solid (483mg, 89%) 
 
 
(2R, 3R)-2-Amino-N-isopropyl-3-methylpentanamide 7. 
 














The white crystalline solid 6 (483 mg, 0.89 mmol) was dissolved in anhydrous 
dichloromethane (10 ml), followed by the addition of trifluoroacetic acid (0.68 ml, 8.9 
mmol) in one portion at 0 oC. After 1 h of stirring at room temperature, excess 
trifluoroacetic acid was removed at reduced pressure and the TFA salt was washed with 
dichloromethane (10mlx3), neutralised with 2N NaOH (20 ml) and then extracted 
dichloromethane (10mlx4). The combined organic extracts were dried over anhydrous 
magnesium sulfate, filtered and concentrated in vacuo to give a white solid (288 mg, 94 
%).   
1H NMR (300 MHz, CDCl3), δ=0.71-0.78(m, 6H), 0.93-0.98(m, 6H), 1.21-1.22(m, 1H), 
1.73-1.76 (m, 1H), 3.02-3.06 (m, 1H), 3.84-3.91 (m, 1H); 13C NMR (75 MHz, CDCl3), 
δ=15.9, 22.4, 22.5, 23.5, 37.9, 40.5, 59.5, 173.3. MS (ESI): m/e calculated for compound 
7 [MH+]: 173, found 173. 
 












A 50 ml rbf was equipped with a mechanical stirrer and charged with 10 ml of DCM, 10 
ml of saturated aqueous sodium bicarbonate, and (85.6 mg, 0.5 mmol) of 6. The biphasic 
mixture is cooled in an ice bar and stirred mechanically while (50 mg, 0.167 mmol) of 
trisphosgene was added in a single portion. The reaction mixture was stirred in the ice bar 
for 15 minutes and then poured into a 100 ml seperatory funnel. The organic layer was 
collected, and the aqueous layer was extracted with three 10 ml portions of DCM. The 
combined organic layer was concentrated to dryness under reduced pressure to afford the 
desired compound 8 as colorless oil (75.3 mg) which was used without further 
purification.  
1-((1R, 2R)-1-(Isopropylcarbamoyl)-2-methylbutyl)-3-((1-benzylpyrrol- 














5 8 9  
(s)1-Benzyl 2-amino methyl pyrrolidine 5 (73 mg, 0.38 mmol) in anhydrous DCM was 
added 8 (75.3 mg, 0.38 mmol) in 5 ml anhydrous DCM dropwise and stirred at room 
temperature overnight. The solvent was evaporated and purified by column 
chromatography (EA: methanol: trimethylamine=100:10:1) to afford a slightly yellow 
solid (102 mg, 69%) 
1H NMR(300 MHz, CDCl3), δ=0.80-0.86 (m, 6H), 1.00-1.06 (m, 6H), 1.58-1.82 (m, 6H) 
2.02-2.24 (m,1H), 2.55-2.63 (m, 1H), 2.80-2.89 (m, 2H),3.16-3.27 (m, 2H), 3.40-3.43 (m, 
1H), 3.85-3.99 (m, 3H), 7.21-7.25 (m, 5H). 13C NMR (75 MHz, CDCl3), δ=11.2, 15.4, 
22.3, 22.5, 22.7, 25.0, 37.5, 41.2, 42.3, 54.2, 54.4, 58.5, 58.7, 58.9, 63.2, 126.9, 128.2, 
128.3, 128.67, 128.86, 139.02, 139.11, 158.79, 172.03.  MS (ESI): m/e calculated for 

























Urea 9 (102 mg, 0.26 mmol) was suspended in MeOH (5 ml) and methanolic HCl (5%, 
10 ml) was added dropwise to form a clear solution. The solvent was removed under 
reduced pressure. The residue was then dissolved in MeOH (5 ml) and the solvent was 
removed under reduced pressure. This process was repeated for three times after which 
Pd/C (10%, 30 mg) was added. The mixture that resulted was allowed to stir at room 
temperature under an atmosphere of hydrogen for overnight. The catalyst was removed 
by filtration. And the residue was washed with Methanol (3×10 ml). The solvent was 
removed under reduced pressure. The residue was dissolved in a mixture of DCM and 
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15% aqueous NaHCO3 (20 ml). The aqueous layer was extracted with DCM (2×10 ml) 
and dried over anhydrous sodium sulfate. Removal of the solvent under pressure afforded 
a white solid (54.2 mg, 70%)  
1H NMR (300 MHz, CDCl3), δ=1.52-1.54 (m, 6H), 1.73-1.75 (m, 6H), 1.87-1.92 (m, 1H), 
2.12-2.24 (m, 1H), 2.39-2.65 (m, 4H), 3.89-3.91 (m, 2H), 3.96-3.98 (m, 1H), 4.35 (s, 1H), 
4.54-4.60 (m, 2H). 13C NMR (75 MHz, CDCl3), δ=11.0, 15.4, 21.7, 21.8, 24.2, 25.0, 27.3, 
37.9, 41.5, 41.8, 45.8, 59.4, 61.7, 78.8, 161.0, 173.2. MS (ESI): m/e calculated for 
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